Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X1050.Time spend outdoors in summer,46692,-0.0229352837562465,0.0562577568003404,-0.133200487084914,0.0873299195724208,0.683511861422885
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X1060.Time spent outdoors in winter,44873,0.00269973116520169,0.0638884878563751,-0.122521705033294,0.127921167363697,0.966294400362943
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X1070.Time spent watching television (TV),47406,-0.0830969771776668,0.0551285816969425,-0.191148997303674,0.0249550429483405,0.131742833347886
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X1080.Time spent using computer,44865,0.0629522558996958,0.0563001429868231,-0.0473960243544774,0.173300536153869,0.263517546283385
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X1090.Time spent driving,42670,-0.029655760362165,0.0624545949863809,-0.152066766535472,0.0927552458111416,0.634910439464643
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X1160.Sleep duration,48293,-0.0414763806631759,0.0510368419661737,-0.141508590916876,0.0585558295905245,0.416414073057181
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,34631,0.00315431431758322,0.0106961300398787,-0.0178101005605789,0.0241187291957454,0.768078596369149
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,34631,-0.0109396716654754,0.0119140283918197,-0.0342911673134419,0.0124118239824912,0.358541626609148
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,34631,0.00672433458127088,0.0125543854809827,-0.0178822609614552,0.031330930123997,0.592243452005904
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,34631,-0.0108761195982741,0.0129712423295576,-0.036299754564207,0.0145475153676587,0.401794737578026
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,34631,-0.00173145022606522,0.0130789622998434,-0.0273662163337583,0.0239033158816279,0.894684690567051
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,34631,-0.0145079949136231,0.035810851211364,-0.0846972632878965,0.0556812734606504,0.685397458737436
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,34631,0.0106865472143961,0.0414823315012191,-0.0706188225279933,0.0919919169567855,0.796711420014631
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,34631,7.12068026941252e-05,0.0212148709185281,-0.041509940197621,0.0416523538030093,0.997322050793772
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,34631,0.00374155163548843,0.0165453641927397,-0.0286873621822814,0.0361704654532583,0.821100998220055
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,34631,-0.00750802166673164,0.0107934872605302,-0.0286632566973708,0.0136472133639075,0.486701993549846
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#18.Location of pain during the past week_Upper back,34631,0.00306002200314888,0.017113983796521,-0.0304833862380322,0.03660343024433,0.858098837893903
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#19.Location of pain during the past week_Lower back,34631,0.00201026528926193,0.00810276312755224,-0.0138711504407405,0.0178916810192643,0.804068369880652
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,34631,0.00413897973208996,0.0109897853097053,-0.0174009994749324,0.0256789589391123,0.706468812650426
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,34631,0.000182566532955034,0.0174408525408588,-0.0340015044471282,0.0343666375130382,0.991648440408308
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,34631,0.00319096670034902,0.0161059533370535,-0.0283767018402758,0.0347586352409738,0.842955172083569
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,34631,0.0114534147816232,0.0195226841019827,-0.0268110460582629,0.0497178756215093,0.557445883103351
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,34631,-0.0027082985490079,0.0195425349845405,-0.0410116671187072,0.0355950700206914,0.889782872147373
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#7.Location of pain during the past week_Left hip,34631,-0.0133812441022412,0.0123337462247018,-0.0375553867026568,0.0107928984981743,0.277996283747566
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#8.Location of pain during the past week_Right hip,34631,0.00321135906653748,0.0120755431868651,-0.0204567055797181,0.0268794237127931,0.790295203288025
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,34631,-1.70273522819839e-05,0.0134803454488465,-0.0264385044320211,0.0264044497274572,0.998992214644692
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120040.Fatigue severity over the past week,34640,-0.0795204440485115,0.0977457062236845,-0.271102028246933,0.11206114014991,0.415938243582005
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120041.Waking unrefreshed severity over the past week,34642,-0.00991083312016199,0.0960696559541785,-0.198207358790352,0.178385692550028,0.917837036367224
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120042.Cognitive symptoms severity over the past week,34641,0.046730607026278,0.105490108371197,-0.160030005381268,0.253491219433824,0.657791962198901
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120098.Mobility problems today,34643,-0.0803354896336501,0.113678704205879,-0.303145749877173,0.142474770609873,0.479787028197869
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120099.Self-care problems today,34643,-0.11151217461774,0.171341047567147,-0.447340627849348,0.224316278613869,0.515187467278581
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120100.Problems doing usual activities,34643,-0.0058840731530199,0.109024727890826,-0.219572539819038,0.207804393512998,0.956960788077295
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120101.Pain or discomfort today,34643,0.0322785686971785,0.0965503027558762,-0.156960024704339,0.221517162098696,0.738150711871613
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120102.Anxiety or depression today,34643,-0.104310410978581,0.125061877136182,-0.349431690165497,0.140810868208335,0.404274293378739
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120103.Scale to indicate how health is today,34630,0.000951971976673731,0.00352615131758235,-0.00595928460578767,0.00786322855913513,0.787188883580005
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,34629,-0.165175240215654,0.123672532479208,-0.407573403874901,0.0772229234435927,0.181735228545698
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",34627,-0.153045262473195,0.130974582146705,-0.409755443480736,0.103664918534346,0.242646868041854
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",34631,-0.0201272744765216,0.0990129969709571,-0.214192748539597,0.173938199586554,0.83892373802757
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,34636,-0.0305275297594025,0.0999125176536122,-0.226356064360482,0.165301004841677,0.759963474664817
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,34636,-0.268638456356719,0.145996214754662,-0.554791037275856,0.0175141245624188,0.0658118712652396
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120109.Feeling bad about self over the last two weeks,34624,0.0606251250270234,0.137632499708242,-0.209134574401132,0.330384824455178,0.659601298214569
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120110.Trouble concentrating over the last two weeks,34640,-0.173489546876816,0.13257426422479,-0.433335104757404,0.0863560110037717,0.190712364369432
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,34634,-0.366487104300347,0.198572841499977,-0.755689873640302,0.0227156650396088,0.0649985005733848
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,34602,0.0445813445715683,0.26035846792214,-0.465721252555827,0.554883941698963,0.864048197745006
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",32333,0.0883683863608881,0.139947244811911,-0.185928213470458,0.362664986192234,0.52779109328656
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X1269.Exposure to tobacco smoke at home,46133,-0.119163205845534,0.12582243663138,-0.365775181643038,0.12744876995197,0.343613933095105
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,45122,0.0377305925915487,0.0702668772275359,-0.0999924867744216,0.175453671957519,0.591301588730152
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X1289.Cooked vegetable intake,47502,-0.0883829206301746,0.0537669523582164,-0.193766147252279,0.0170003059919295,0.100231062028558
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X1299.Salad  or  raw vegetable intake,46806,-0.0471302030261455,0.0555516255439579,-0.156011389092303,0.0617509830400121,0.396224353883496
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X1309.Fresh fruit intake,47382,-0.0156074124075019,0.0569629331012181,-0.127254761285889,0.0960399364708856,0.784093453069167
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X1319.Dried fruit intake,46542,-0.0398904335181849,0.0605896315126982,-0.158646111283073,0.0788652442467035,0.510308454858693
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X134.Number of self-reported cancers,48420,-0.093131249517363,0.115159660264019,-0.318844183634841,0.132581684600115,0.418689281931062
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X135.Number of self-reported non-cancer illnesses,48421,-0.0264668342491936,0.0529702525357069,-0.130288529219179,0.077354860720792,0.617323799766061
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X136.Number of operations, self-reported",48421,-0.02827245556104,0.0504231299115144,-0.127101790187608,0.0705568790655283,0.575005611424914
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X137.Number of treatments or medications taken,48421,0.0188871797355499,0.0525400917743035,-0.084091400142085,0.121865759613185,0.719238905154959
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X1438.Bread intake,47968,0.00246516476150893,0.00190192744559825,-0.00126261303186365,0.0061929425548815,0.194942606074331
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X1458.Cereal intake,47391,-0.03001057796358,0.0531495327284607,-0.134183662111363,0.0741625061842029,0.572322502416066
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X1488.Tea intake,47677,0.00118692475732828,0.00187379592667946,-0.00248571525896347,0.00485956477362003,0.52645831162896
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X1498.Coffee intake,46878,0.0622471466309812,0.053250839835154,-0.0421244994459206,0.166618792707883,0.242442219836905
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X1528.Water intake,46670,0.0363461779044127,0.0537292664303696,-0.0689631842991116,0.141655540107937,0.498751642307472
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X1568.Average weekly red wine intake,43685,0.0202707891275197,0.0601018031525671,-0.0975287450515119,0.138070323306551,0.735914880212983
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,43688,-0.0408778414573569,0.0627795332796141,-0.163925726685401,0.0821700437706868,0.514970392257202
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X1588.Average weekly beer plus cider intake,43741,-0.121492182400705,0.0624072386951288,-0.243810370243158,0.000826005441747421,0.0515814713634505
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X1598.Average weekly spirits intake,43686,-0.0120556224247302,0.0644058980539165,-0.138291182610407,0.114179937760946,0.851520483703767
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X1608.Average weekly fortified wine intake,43717,-0.126009746608741,0.116090753433102,-0.353547623337621,0.101528130120139,0.277743374726666
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X1737.Childhood sunburn occasions,43212,-0.0319195747006657,0.0625820009921335,-0.154580296645247,0.090741147243916,0.610028334200851
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X1807.Father's age at death,43355,0.000234039362379022,0.00214266839561686,-0.00396559069303002,0.00443366941778806,0.91302314556542
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X1845.Mother's age,35932,0.000623497829744902,0.00496507113234333,-0.00910804158964802,0.0103550372491378,0.900070357839176
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X1873.Number of full brothers,48087,0.0617281493878029,0.0516212375342758,-0.0394494761793776,0.162905774954983,0.231793147806291
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X1883.Number of full sisters,48088,-0.00811263063113684,0.0514234256272961,-0.108902544860637,0.0926772835983636,0.874646465744468
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X20015.Sitting height,48246,0.00254072164030011,0.00245004195960461,-0.00226136060052493,0.00734280388112515,0.299743270059033
PRAME,Melanoma antigen preferentially expressed in tumors,Cognitive function,X20016.Fluid intelligence score,35035,0.0916175408181492,0.0865462809241826,-0.0780131697932486,0.261248251429547,0.28982364958514
PRAME,Melanoma antigen preferentially expressed in tumors,Cognitive function,X20018.Prospective memory result,35331,-0.155415863769165,0.111744359427653,-0.374434808247364,0.0636030807090339,0.164327155931178
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),34960,0.00402558219660145,0.00326346932725367,-0.00237081768481573,0.0104219820780186,0.217424261079067
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),34965,0.00460422612962803,0.0032480611356739,-0.00176197369629281,0.0109704259555489,0.156376796140594
PRAME,Melanoma antigen preferentially expressed in tumors,Cognitive function,X20023.Mean time to correctly identify matches,48173,0.00123483020417403,0.00192281031086707,-0.00253387800512543,0.0050035384134735,0.520750374101571
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20107#1.Illnesses of father_Heart disease,45545,-0.00300478831164574,0.00428379567384449,-0.0114010278323809,0.00539145120908947,0.483043535324482
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,45176,0.0107101174063048,0.00955025806367811,-0.00800838839850432,0.0294286232111139,0.262113477428606
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,45143,0.0137025916870083,0.0125299636174494,-0.0108561370031925,0.038261320377209,0.274152554293369
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20107#12.Illnesses of father_Severe depression,45164,-0.0105998158296225,0.0112936681984487,-0.0327354054985819,0.0115357738393369,0.34796899120128
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,45185,0.0173198750013948,0.00755174238071385,0.00251845993519565,0.032121290067594,0.0218320337176565
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20107#2.Illnesses of father_Stroke,45325,-0.000794027060603768,0.0054450945036061,-0.0114664122876717,0.00987835816646418,0.884061854595091
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20107#3.Illnesses of father_Lung cancer,45287,-0.00429463696677675,0.00695859583331702,-0.0179334848000781,0.00934421086652461,0.537130986313891
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,45189,-0.00620463127426267,0.00840326147804953,-0.0226750237712397,0.0102657612227144,0.460306222971846
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,45304,0.00349691938060052,0.00645533636201778,-0.00915553988895432,0.0161493786501554,0.588025618878375
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20107#8.Illnesses of father_High blood pressure,45376,-0.00134946991756502,0.0048413039867334,-0.0108384257315625,0.00813948589643244,0.780447030764598
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20107#9.Illnesses of father_Diabetes,45255,0.00863260069434624,0.00663572639704711,-0.00437342304386609,0.0216386244325586,0.193301180034925
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20110#1.Illnesses of mother_Heart disease,46175,0.00044640869143288,0.00510383527539293,-0.00955710844833727,0.010449925831203,0.930302630377946
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,46049,-0.00163604179211378,0.00718325660082854,-0.0157152247297377,0.0124431411455102,0.81983730420555
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,45979,-0.00934431384719489,0.0161563814533475,-0.0410108214957559,0.0223221938013662,0.56302403125347
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20110#12.Illnesses of mother_Severe depression,46009,-0.00385875351275128,0.00850697492727574,-0.0205324243702117,0.0128149173447092,0.650123280299464
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20110#2.Illnesses of mother_Stroke,46128,-0.00349657562223112,0.0057575303113441,-0.0147813350324655,0.00778818378800332,0.543656540267775
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,46050,-0.00353190199338851,0.00966373994399863,-0.0224728322836258,0.0154090282968488,0.714757693185376
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,46017,0.00307385936805142,0.00877806436010719,-0.0141311467777587,0.0202788655138615,0.726211543784523
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,46025,-0.000136830505724155,0.00736514355747659,-0.0145725118783783,0.01429885086693,0.98517787187735
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,46056,0.00385760636557616,0.00866358066247259,-0.0131230117328701,0.0208382244640224,0.656132351498066
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,46226,-0.00047597882431523,0.00438329674796787,-0.00906724045033226,0.00811528280170179,0.913529538502754
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20110#9.Illnesses of mother_Diabetes,46102,0.0115889979810595,0.00661873427998247,-0.00138372120770618,0.0245617171698251,0.0799739879420488
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,43647,-0.0105984572626531,0.00707352339303801,-0.0244625631130076,0.00326564858770135,0.134069063025439
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,43524,0.0275871169176491,0.029444772048874,-0.0301246362981439,0.0852988701334421,0.34881974425853
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,43519,-0.00999097763206976,0.0277011588627373,-0.0642852490030349,0.0443032937388954,0.718351242199182
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,43566,0.00585089156356328,0.00923748891549656,-0.01225458671081,0.0239563698379365,0.526491608246155
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,43532,-0.00854003625834655,0.0164914501920166,-0.040863278634699,0.0237832061180059,0.604573192034188
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20111#2.Illnesses of siblings_Stroke,43562,0.00667905259900334,0.0118600823509424,-0.0165667088088439,0.0299248140068505,0.573338474417083
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,43536,0.0184800729538948,0.0135036710094953,-0.0079871222247159,0.0449472681325056,0.171169275396422
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,43543,0.00341026058355224,0.0132012637649863,-0.0224642163958209,0.0292847375629254,0.79615707221978
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,43548,0.00500143397338673,0.0103817910895565,-0.0153468765621441,0.0253497445089175,0.629990186515576
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,43562,0.00165987840493223,0.0131788120256238,-0.0241705931652904,0.0274903499751548,0.899772773528651
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,43704,-0.00429277146610128,0.00536566173430139,-0.014809468465332,0.00622392553312944,0.423697240608512
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,43621,0.000692726224441165,0.00748031881473214,-0.0139686986524338,0.0153541511013162,0.926217406175107
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20127.Neuroticism score,44529,0.0410409717244774,0.0532378334345668,-0.0633051818072736,0.145387125256228,0.440778473877141
PRAME,Melanoma antigen preferentially expressed in tumors,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,35035,-0.00132292914474606,0.0890442978195527,-0.175849752871069,0.173203894581577,0.988146744337822
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X20161.Pack years of smoking,35592,-0.00426812359045263,0.00316903998344477,-0.0104794419580044,0.00194319477709912,0.178082151645147
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,35592,-0.00427636871660462,0.00312509494382403,-0.0104015548064997,0.00184881737329047,0.171231992861999
PRAME,Melanoma antigen preferentially expressed in tumors,Cognitive function,X20191.Fluid intelligence score,33190,0.0360657923559531,0.0997116632869622,-0.159369067686493,0.231500652398399,0.717592292126374
PRAME,Melanoma antigen preferentially expressed in tumors,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,33191,-0.0476143291401022,0.100978984142897,-0.24553313806018,0.150304479779975,0.637286825970932
PRAME,Melanoma antigen preferentially expressed in tumors,Cognitive function,X20240.Maximum digits remembered correctly,32756,0.0637557700323773,0.109557746487986,-0.150977413084074,0.278488953148829,0.56064035024317
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X20255.Spirometry QC measure,42689,-0.082055007665503,0.0652879508897481,-0.210019391409409,0.0459093760784033,0.208840735579991
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X20261.avMSE,33042,-0.00151625642283014,0.00407257126733061,-0.00949849610679812,0.00646598326113785,0.709680287743392
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X20262.Myopia diagnosis,33042,-0.0166282869819417,0.130388472364458,-0.27218969281628,0.238933118852397,0.898527644564497
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X20280.Glucose-lactate,39539,0.00475330907179375,0.00243220072214465,-1.38043436097666e-05,0.00952042248719727,0.0506883132247852
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X20281.Spectrometer-corrected alanine,39557,0.0012338226175939,0.00257502495436072,-0.0038132262929531,0.00628087152814091,0.631841646578397
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,34705,-0.0222031004658381,0.0157780301935227,-0.0531280396451427,0.00872183871346646,0.1594141826165
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,34705,-0.0199769102928605,0.0343585070006405,-0.0873195840141159,0.0473657634283949,0.560975216657472
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),34707,-0.0602765279070164,0.0404564446068327,-0.139571159336408,0.0190181035223756,0.136299111136158
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),34707,-0.0136973726118993,0.0153095421799787,-0.0437040752846576,0.0163093300608589,0.370985349959961
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),34707,0.0185015807298733,0.0212256508057971,-0.023100694849489,0.0601038563092356,0.383427383527228
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,34709,0.00553525607525797,0.0292107073630731,-0.0517177303563652,0.0627882425068812,0.849711891023093
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,34709,0.00783837629038907,0.019059150510461,-0.0295175587101145,0.0451943112908926,0.680892089635924
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,34709,-0.00884075984890352,0.0213003307150395,-0.050589408050381,0.032907888352574,0.67811789730759
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,34709,0.012713103437394,0.0312693101824143,-0.048574744520138,0.074000951394926,0.684339486641444
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,34709,-0.027761723191603,0.0334839252276885,-0.0933902166378725,0.0378667702546665,0.407076824279984
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,34709,0.0176088366132549,0.0225826238481488,-0.0266531061291168,0.0618707793556265,0.435567319542243
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,34709,-0.0335499218655413,0.0324434262293956,-0.0971390372751568,0.0300391935440741,0.301127831718197
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,34709,-0.0123413128748183,0.0257996914912905,-0.0629087081977477,0.0382260824481111,0.632417392429725
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),34711,0.0093936090290621,0.0443447026379527,-0.0775220081413252,0.0963092261994494,0.832245483937451
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),34711,0.0131261054951473,0.0204357107157717,-0.0269278875077652,0.0531800984980599,0.520694615057732
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),34711,0.0098721977857278,0.0259629082163261,-0.0410151023182713,0.0607594978897269,0.703778724436512
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,34711,0.0516248594835186,0.0539307241131154,-0.0540793597781875,0.157329078745225,0.338482004890979
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20600.Liking for adding salt to foods,35146,-0.0555506437366101,0.0868593351909864,-0.225794940710944,0.114693653237723,0.522489436038891
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20601.Liking for aniseed,35146,0.0902613026820975,0.0857444850062,-0.0777978879300545,0.25832049329425,0.292527665949525
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20602.Liking for apple juice,35146,0.11577470001626,0.086499885092512,-0.0537650747650636,0.285314474797584,0.180800372097441
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20603.Liking for apples,35146,0.0451730445057761,0.0852682344207448,-0.121952694958884,0.212298783970436,0.596285398687206
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20604.Liking for asparagus,35146,0.0689622375736242,0.084942047856525,-0.0975241762251648,0.235448651372413,0.416893513919196
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20605.Liking for aubergine,35146,0.184048874169447,0.0848099751554463,0.0178213228647719,0.350276425474121,0.0300327100610939
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20606.Liking for avocados,35146,0.254807765567007,0.0848303845386339,0.0885402118712849,0.42107531926273,0.00267700013361045
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20607.Liking for bacon,35146,-0.165638461594344,0.088433141923478,-0.338967419764361,0.00769049657567333,0.0611080014267103
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20608.Liking for baked or steamed fish,35146,-0.00854326495228321,0.0879791688403214,-0.180982435879313,0.163895905974747,0.922645555995954
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20609.Liking for bananas,35146,0.0441638738075208,0.088507091881435,-0.129310026280092,0.217637773895133,0.61780544816995
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20610.Liking for barbequed or grilled meat,35146,-0.192403060407738,0.0869376664413676,-0.362800886632819,-0.0220052341826576,0.0269241252212542
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20611.Liking for beef steak,35146,-0.195591801533474,0.087900579582095,-0.36787693751438,-0.0233066655525678,0.0261052953475163
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20612.Liking for beetroot,35146,-0.0219682540021799,0.0864396104986031,-0.191389890579442,0.147453382575082,0.799391003788295
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20613.Liking for bell pepper,35146,0.0178465971013596,0.0855483716619587,-0.149828211356079,0.185521405558799,0.834755997219211
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20614.Liking for bicycling,35146,0.054372827946239,0.0854639054969063,-0.113136426827697,0.221882082720175,0.524663075951091
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20615.Liking for biscuits,35146,0.0126768792929327,0.0849302933042416,-0.153786495583381,0.179140254169246,0.88135137463524
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20616.Liking for bitter foods,35146,0.0352728885165941,0.0867377203278341,-0.134733043325961,0.205278820359149,0.684269958999203
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20617.Liking for bitter or ale,35146,-0.0920563886903183,0.0858139704515648,-0.260251770775385,0.0761389933947487,0.283425765857373
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20618.Liking for black olives,35146,0.148205193436463,0.0847805460089997,-0.0179646767411768,0.314375063614102,0.0804930016543728
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20619.Liking for black pepper,35146,0.186788412511546,0.0856597205329094,0.0188953602670436,0.354681464756049,0.0292495648991477
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20620.Liking for blue cheese,35146,0.0777895782458912,0.0863169487243173,-0.0913916412537707,0.246970797745553,0.367510609534014
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20621.Liking for bolognese sauce,35146,-0.0539892521885095,0.0865987972190243,-0.223722894737797,0.115744390360778,0.533016426738195
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20622.Liking for broad beans,35146,0.0791857652135269,0.0836432012139784,-0.0847549091658708,0.243126439592925,0.343822113513069
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20623.Liking for broccoli,35146,0.0709441889382398,0.0849235560871239,-0.0955059809925231,0.237394358869003,0.403529355922692
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20624.Liking for brown rice,35146,0.0500271084685802,0.0850180454885094,-0.116608260688898,0.216662477626059,0.55626450937952
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20625.Liking for brussel sprouts,35146,0.053958319253526,0.0850029180273673,-0.112647400080114,0.220564038587166,0.525592843469894
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20626.Liking for burgers (meat),35146,-0.1152873321039,0.0858118071780627,-0.283478474172903,0.0529038099651026,0.179159893132816
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20627.Liking for burn of spicy foods,35146,-0.0477443397568053,0.0849165852153628,-0.214180846778916,0.118692167265306,0.573965060298915
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20628.Liking for butter on bread,35146,-0.0111182574221602,0.0861905360942833,-0.180051708166955,0.157815193322635,0.897364570992804
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20629.Liking for butternut squash,35146,0.0914641296650383,0.0848731028133132,-0.0748871518490554,0.257815411179132,0.281226429205859
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20630.Liking for cabbage,35146,0.0991834513194135,0.0861258021803362,-0.0696231209540455,0.267990023592873,0.249522932120501
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20631.Liking for cake,35146,0.0881859240223671,0.0850183197326912,-0.0784499826537076,0.254821830698442,0.299654045490827
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20632.Liking for cake icing,35146,0.100019208329871,0.0857029496581104,-0.0679585730000258,0.267996989659767,0.243234722040867
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20633.Liking for capers,35146,0.129692212650879,0.0851889174175407,-0.0372780654875009,0.296662490789258,0.127955476761648
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20634.Liking for cauliflower,35146,0.0466765068706456,0.0856116555276675,-0.121122337963583,0.214475351704874,0.585626280471872
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20635.Liking for cereal or granola bar,35146,0.0697024336585525,0.0859597039123497,-0.098778586009653,0.238183453326758,0.417467922441168
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20636.Liking for cheesecake,35146,0.0431214671256251,0.0847982979482402,-0.123083196852926,0.209326131104176,0.611107227838387
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20637.Liking for cherries,35146,0.125402317790857,0.0851868996466963,-0.0415640055166678,0.292368641098382,0.141046190536572
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20638.Liking for chicken,35146,-0.0683177940083419,0.0915127833110555,-0.247682849298011,0.111047261281327,0.455369175661824
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20639.Liking for chilli pepper,35146,0.0143264635767918,0.0842913202878717,-0.150884524187437,0.17953745134102,0.865043954174063
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20640.Liking for chips or french fries,35146,-0.100098480074641,0.0860354796706172,-0.26872802022905,0.0685310600797689,0.244687076048457
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20641.Liking for cigarette smoking,35146,-0.119639859778288,0.133951664947112,-0.382185123074628,0.142905403518053,0.371806010150448
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20642.Liking for cod,35146,-0.0274629623955907,0.0896099158512464,-0.203098397464034,0.148172472672852,0.759254782067794
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20643.Liking for coffee with sugar,35146,0.0787853815570165,0.0880985262549178,-0.0938877299026225,0.251458493016655,0.371201187741771
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20644.Liking for coffee without sugar,35146,0.0621675204885288,0.0866958142372897,-0.107756275416559,0.232091316393617,0.473352590216688
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20645.Liking for coriander,35146,0.0906330511872927,0.0830916707187987,-0.0722266234215528,0.253492725796138,0.275418808038426
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20646.Liking for corn flakes,35146,0.0232151988067581,0.0852983140346008,-0.14396949670106,0.190399894314576,0.785503899578587
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20647.Liking for cream,35146,-0.0211395274866499,0.0854028593199253,-0.188529131753703,0.146250076780404,0.804508046169757
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20648.Liking for croissant,35146,0.032393422933232,0.0844842581161718,-0.133195722974465,0.197982568840929,0.701416732449385
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20649.Liking for cucumber,35146,0.128467536193274,0.0841121134689738,-0.036392206205915,0.293327278592462,0.126725634821581
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20650.Liking for curry,35146,-0.0651755712037177,0.0874125094144803,-0.236504089656099,0.106152947248664,0.455930332236922
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20651.Liking for dairy products,35146,0.0965918922509371,0.0877388484157735,-0.0753762506439791,0.268560035145853,0.270979755008289
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20652.Liking for dark chocolate,35146,-0.102305256491045,0.0855267452484788,-0.269937677178063,0.0653271641959735,0.231670281337826
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20653.Liking for diet fizzy drinks,35146,-0.073201867106889,0.0866134574990441,-0.242964243805015,0.0965605095912374,0.398054781041303
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20654.Liking for dried fruit,35146,0.0393165989736141,0.0852934032742038,-0.127858471443825,0.206491669391054,0.64484472628786
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20655.Liking for eggs,35146,-0.080131817411993,0.0863814944649851,-0.249439546563364,0.0891759117393778,0.353623256686572
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20656.Liking for exercising alone,35146,0.0210276980919024,0.0852056639667291,-0.145975403282887,0.188030799466691,0.805080386175164
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20657.Liking for exercising with others,35146,0.0783255424500651,0.0841947612873074,-0.0866961896730573,0.243347274573188,0.352255318923856
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20658.Liking for extra virgin olive oil,35146,0.0248166146693108,0.0867117897117213,-0.145138493165663,0.194771722504285,0.774736658478511
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20659.Liking for fatty foods,35146,0.017017525028181,0.0855625422905353,-0.150685057861268,0.18472010791763,0.842355059799654
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20660.Liking for fresh tomatoes,35146,0.19685319655134,0.0882665673557046,0.0238507245341587,0.369855668568521,0.0257671588094703
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20661.Liking for fried chicken,35146,-0.0997529566477695,0.0866618278835373,-0.269610139299503,0.0701042260039636,0.249749685897182
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20662.Liking for fried or battered fish,35146,-0.118938613829106,0.0877901598269993,-0.291007327090025,0.0531300994318122,0.175526270863974
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20663.Liking for fruit,35146,0.0738329446943443,0.0904953506985757,-0.103537942674864,0.251203832063553,0.41460104015385
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20664.Liking for garlic,35146,0.0937033279614926,0.0850333231902139,-0.0729619854913266,0.260368641414312,0.270519595254261
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20665.Liking for gherkins,35146,-0.00038541344566492,0.0845122279768643,-0.166029380280319,0.165258553388989,0.996361442376055
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20666.Liking for globe artichoke,35146,0.135066182010766,0.0853715843318021,-0.0322621232795658,0.302394487301098,0.113675659941604
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20667.Liking for goat's cheese,35146,0.0435687158229421,0.0837754014331598,-0.120631070986051,0.207768502631935,0.603035369628578
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20668.Liking for going to a cafe,35146,0.00733754563994415,0.0844635999563286,-0.15821111027446,0.172886201554348,0.930775693017513
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20669.Liking for going to the gym,35146,-0.0107410370871305,0.0840108837196907,-0.175402369177724,0.153920295003463,0.898269299568583
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20670.Liking for going to the pub,35146,-0.0606664159267061,0.0858792933517803,-0.228989830896195,0.107656999042783,0.479955308710292
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20671.Liking for grapefruit,35146,0.0408615973325187,0.0833791396305663,-0.122561516343391,0.204284711008429,0.624100962212208
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20672.Liking for green olives,35146,0.150411777194707,0.0842378037065218,-0.0146943180700758,0.31551787245949,0.0742166333189271
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20673.Liking for haddock,35146,-0.0464099272459196,0.0890856031182299,-0.22101770935765,0.128197854865811,0.602413131288329
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20674.Liking for ham,35146,-0.100732998380774,0.0877406299943663,-0.272704633169732,0.0712386364081835,0.250978793502895
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20675.Liking for hard cheese,35146,0.0236728252401732,0.0870630230322911,-0.146970699903117,0.194316350383464,0.785704059997696
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20676.Liking for herring,35146,0.000333976704198505,0.0872471461711193,-0.170670429791195,0.171338383199592,0.9969458712868
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20677.Liking for honey,35146,-0.0020987711255756,0.0839014406599883,-0.166545594819153,0.162348052568002,0.980043985188924
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20678.Liking for horseradish or wasabi,35146,0.0372873453626132,0.0843594817606777,-0.128057238888315,0.202631929613542,0.658499929589977
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20679.Liking for ice cream,35146,-0.0255219954155492,0.0867158894203703,-0.195485138679475,0.144441147848377,0.768524720186139
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20680.Liking for jam,35146,0.0696384682688616,0.0844837928552025,-0.0959497657273353,0.235226702265059,0.409809427545101
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20681.Liking for kiwi fruit,35146,0.0765644784839768,0.0849209743535958,-0.0898806312490709,0.243009588217025,0.367304309483691
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20682.Liking for lager,35146,0.0996626518932984,0.0840892969873824,-0.065152370201971,0.264477673988568,0.235981382917828
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20683.Liking for lamb,35146,0.0185327042098803,0.0879559608338129,-0.153860979024393,0.190926387444154,0.833124541569281
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20684.Liking for lemons,35146,0.139592092983353,0.0849726794485449,-0.0269543587357952,0.306138544702501,0.100474911996304
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20685.Liking for lentils or beans,35146,0.0526979866600636,0.0853307464059303,-0.11455027629556,0.219946249615687,0.53687819196286
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20686.Liking for liver,35146,-0.231619204505405,0.0866279711931195,-0.40141002804392,-0.0618283809668912,0.00752008392561703
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20687.Liking for mackerel,35146,0.0875279516531442,0.0867326420367098,-0.082468026738807,0.257523930045095,0.312930622241896
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20688.Liking for marzipan,35146,0.138799713664226,0.0852292245290229,-0.0282495664126586,0.305848993741111,0.103457348841522
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20689.Liking for mayonnaise,35146,-0.0643870075424946,0.086151761229663,-0.233244459552634,0.104470444467645,0.45486877152949
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20690.Liking for melon,35146,0.144594551460162,0.0858053894026956,-0.0235840117691213,0.312773114689446,0.0920082659846148
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20691.Liking for milk chocolate,35146,-0.0652649678871883,0.085872269241057,-0.23357461559966,0.103044679825283,0.447267770935706
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20692.Liking for mushrooms,35146,-0.0127783290156856,0.0861873051572866,-0.181705447123967,0.156148789092596,0.882140331204292
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20694.Liking for orange juice,35146,-0.00823707488137744,0.0844464925807747,-0.173752200339696,0.157278050576941,0.922299018523696
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20695.Liking for oranges,35146,0.0588514683004898,0.0859452833211919,-0.109601287009046,0.227304223610026,0.493522770278742
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20696.Liking for pasta,35146,0.0128408203572148,0.0873045538399926,-0.158276105169171,0.1839577458836,0.883072809674545
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20697.Liking for pears,35146,0.0828456747347503,0.0860094402707387,-0.0857328281958975,0.251424177665398,0.335474732818954
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20698.Liking for pizza,35146,0.143374552771883,0.0860421622648346,-0.0252680852671924,0.312017190810959,0.0956958072890008
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20699.Liking for plain yogurt,35146,0.0224753550142741,0.0847793991308389,-0.14369226728217,0.188642977310718,0.790937730387548
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20700.Liking for plums,35146,0.0579175153200594,0.0850448884543863,-0.108770466050538,0.224605496690657,0.495881132044487
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20701.Liking for pollock,35146,-0.0459696299064997,0.0858658308226875,-0.214266658318967,0.122327398505968,0.59241514050046
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20702.Liking for pork chop,35146,-0.119020405084694,0.0869418269276917,-0.28942638586297,0.0513855756935815,0.171056938495309
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20703.Liking for porridge,35146,-0.0882287041708136,0.0859595172348478,-0.256709357951115,0.0802519496094881,0.304741846976697
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20704.Liking for potato crisps,35146,-0.124589502198959,0.087055135259048,-0.295217567306694,0.0460385629087747,0.152433237872922
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20705.Liking for potatoes,35146,-0.0726569917545889,0.0867137444806684,-0.242615930936699,0.0973019474275213,0.402120443481154
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20706.Liking for prawns,35146,-0.0913738216697167,0.0872047819123864,-0.262295194217994,0.0795475508785607,0.294766060089397
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20707.Liking for raw carrots,35146,0.010320011771741,0.0849498046705466,-0.15618160538253,0.176821628926012,0.903311703428634
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20708.Liking for red meat,35146,-0.243469382986842,0.0887603689271653,-0.417439706084086,-0.0694990598895975,0.00610472217280346
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20709.Liking for red wine,35146,0.130108139165945,0.0859937074582186,-0.0384395274521633,0.298655805784053,0.130329006086349
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,35146,-0.078992374179558,0.0849584538967541,-0.245510943817196,0.0875261954580801,0.352521146762819
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20711.Liking for roast chicken,35146,-0.0633248050356383,0.0907245246124241,-0.241144873275989,0.114495263204713,0.485208314901038
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20712.Liking for salad dressing,35146,0.101179029628176,0.0860427601554103,-0.0674647802764277,0.269822839532781,0.239671400922177
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20713.Liking for salad leaves,35146,0.152929173659408,0.0856886453751446,-0.0150205712758757,0.320878918594691,0.0743551222038961
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20714.Liking for salami,35146,-0.0248912647029487,0.08601451716073,-0.193479718337979,0.143697188932082,0.772296361923706
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20715.Liking for salmon,35146,0.164587949745274,0.0895183803641594,-0.0108680757684783,0.340043975259027,0.0660202745369322
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20716.Liking for salty foods,35146,-0.0101147968050661,0.0857447496424213,-0.178174506104212,0.15794491249408,0.906099777611844
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20717.Liking for salty pretzels,35146,-0.149597834388896,0.084661402881165,-0.315534184035979,0.0163385152581877,0.0772726353139886
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20718.Liking for sardines,35146,-0.0461625231203437,0.0867735670911264,-0.216238714618952,0.123913668378264,0.594752172280228
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20719.Liking for sausages (meat),35146,-0.124968030602498,0.0863195737052953,-0.294154395064877,0.0442183338598807,0.147738606381944
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20720.Liking for savoury biscuits,35146,-0.118167295974717,0.0854714071913154,-0.285691254069695,0.0493566621202616,0.166854418755818
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20721.Liking for shellfish (other than prawns),35146,-0.0737702071570879,0.0863517590662345,-0.243019654926907,0.0954792406127317,0.392970738035002
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20722.Liking for skimmed milk,35146,0.173779761607843,0.0842603749346772,0.00862942673587569,0.33893009647981,0.0392077756445608
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20723.Liking for smoked fish,35146,-0.0533928369297906,0.0874888694515894,-0.224871021054906,0.118085347195325,0.54169657630306
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20724.Liking for soft cheese,35146,0.0420441759338651,0.0859917451437847,-0.126499644547953,0.210587996415683,0.62490574863483
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20725.Liking for soy sauce,35146,0.00341057116322694,0.0851406761225904,-0.16346515403705,0.170286296363504,0.968048053545246
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20726.Liking for soya milk,35146,0.00402510393003024,0.0860762059738245,-0.164684259778666,0.172734467638726,0.962704266274878
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20727.Liking for spicy foods,35146,0.030281612030292,0.0852752506683058,-0.136857879279587,0.197421103340171,0.722522877958407
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20728.Liking for spinach,35146,0.0392249004877953,0.0852732631665263,-0.127910695318596,0.206360496294187,0.645538257788076
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20729.Liking for spirits,35146,-0.0887313861534304,0.0849843353104238,-0.255300683361861,0.0778379110550002,0.296481861980366
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20730.Liking for strawberries,35146,0.046671765962849,0.0879053511166673,-0.125622722225819,0.218966254151517,0.595483922583964
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20731.Liking for sweet coffee house drinks,35146,0.00761718319587042,0.0873430295093255,-0.163575154642408,0.178809521034148,0.930507283854562
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20732.Liking for sweet foods,35146,-0.0349432367472692,0.0842198473090576,-0.200014137473022,0.130127663978484,0.678225056482423
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20733.Liking for taking the stairs,35146,0.0545494063871131,0.0875524985751621,-0.117053490820205,0.226152303594431,0.533274735432925
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20734.Liking for tea with sugar,35146,0.0894210617610512,0.0921699266311955,-0.0912319944360919,0.270074117958194,0.331994606350733
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20735.Liking for tea without sugar,35146,0.0333962463183613,0.0867822327754008,-0.136696929921424,0.203489422558147,0.700377258903724
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20736.Liking for tomato ketchup,35146,-0.00925329426163837,0.0846400598712402,-0.175147811609269,0.156641223085992,0.912947889211779
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20737.Liking for tinned tuna,35146,0.00481990885732577,0.0879910561885826,-0.167642561272296,0.177282378986948,0.95631759199244
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20738.Liking for turnip (white),35146,-0.0612052782311136,0.0858195669115591,-0.229411629377769,0.107001072915542,0.475756381758067
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20739.Liking for vegetables,35146,0.0216718046791934,0.0881425094653115,-0.151087513872817,0.194431123231204,0.80578877854926
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20740.Liking for vinegar,35146,-0.010918244211527,0.0856641644395297,-0.178820006513005,0.156983518089951,0.898584964068191
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20741.Liking for watching television,35146,0.0579392848042864,0.0852706694079414,-0.109191227235279,0.225069796843852,0.496861025432794
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20742.Liking for whisky,35146,0.0123391705939218,0.0844372152535786,-0.153157771303092,0.177836112490936,0.883819901227616
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20743.Liking for white bread,35146,-0.074321510626474,0.0840698423535891,-0.239098401639509,0.0904553803865605,0.376704518136432
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20744.Liking for white rice,35146,-0.135428004695118,0.0850570658176403,-0.302139853697693,0.0312838443074568,0.111387742213705
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20745.Liking for white wine,35146,-0.0462532335737953,0.0860358488755045,-0.214883497369784,0.122377030222194,0.590868631165277
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,35146,0.0940044252615371,0.0849587321033086,-0.0725146896609477,0.260523540184022,0.268563160585022
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20747.Liking for whole milk,35146,0.0212473573706266,0.0839787949681391,-0.143351080766926,0.185845795508179,0.800269522925302
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20748.Liking for wholemeal bread,35146,-0.00943921675399535,0.0873837220429354,-0.180711311958149,0.161832878450158,0.913982896484084
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20749.Liking for working up a sweat,35146,0.0496652625647934,0.08480586699004,-0.116554236735685,0.215884761865272,0.558141208756676
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X21001.Body mass index (BMI),48305,-0.00312599588416835,0.00983011038542374,-0.0223930122395989,0.0161410204712622,0.750486703120756
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X21002.Weight,48329,0.00477513862123897,0.00474426788745152,-0.00452362643816601,0.0140739036806439,0.314184112213607
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X21021.Pulse wave Arterial Stiffness index,35316,-0.00043892294555219,0.00350146507676661,-0.00730179449601475,0.00642394860491037,0.900246989339088
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,34965,-0.0209737878565901,0.090568786180794,-0.198488608770946,0.156541033057766,0.816872822012027
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,34967,0.0510697354544387,0.0924176705439875,-0.130068898811777,0.232208369720654,0.580558745204485
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,34968,0.00279839112541325,0.0890398057751462,-0.171719628193873,0.1773164104447,0.974928765907435
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21040.Satisfaction with bowel habits,34944,-0.0536675022394892,0.0819219223174902,-0.21423446998177,0.106899465502792,0.512423614448256
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,34940,-0.0227207153461191,0.0895558676555202,-0.198250215950939,0.1528087852587,0.799732192958561
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21042.Greatest number of times bowels opened per day,34939,-0.0718878774354463,0.0907599974771749,-0.249777472490709,0.106001717619817,0.428352034544106
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21043.Least number of times bowels opened per week,34911,-0.0804137864666466,0.087624635340433,-0.252158071733895,0.091330498800602,0.358807086260125
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21044.Average number of times bowels opened per day,34922,-0.112230269379917,0.0984840898357401,-0.305259085457967,0.0807985466981338,0.254505522868093
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,34971,0.03068220453041,0.0891177303684614,-0.143988546991774,0.205352956052594,0.730640740499967
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,34966,0.0379888401796171,0.0894988262597031,-0.137428859289401,0.213406539648635,0.671243345287543
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,34971,-0.029597730938691,0.103236955979874,-0.231942164659243,0.172746702781861,0.774353619235992
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,34970,-0.087663643454103,0.127360114598742,-0.337289468067637,0.161962181159431,0.491280662509736
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,34969,0.0746632357633838,0.111538334744847,-0.143951900336515,0.293278371863283,0.503267624709967
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,34967,0.0695632501284932,0.271434665275364,-0.462448693811221,0.601575194068207,0.797742994024367
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,34971,0.0479860178721372,0.111458254657333,-0.170472161256236,0.266444197000511,0.6668253963481
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,34969,0.104062388943202,0.102010206768063,-0.0958776163222025,0.304002394208606,0.307711528905931
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,34851,0.117765759731975,0.104115031251383,-0.086299701520736,0.321831220984687,0.258051367111147
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,34968,-0.0407960747680564,0.0917875343709455,-0.22069964213511,0.139107492598997,0.656723674305722
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,34970,0.235486696063778,0.163728881601436,-0.0854219118750361,0.556395304002591,0.150405975111399
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,34971,0.137563663377767,0.0928038911992318,-0.0443319633727271,0.319459290128262,0.138308650061257
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,34970,-0.0458625875972724,0.0899588431338699,-0.222181920139657,0.130456744945113,0.610197027558979
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X21100.Water hardness (USGS classification),48191,-0.00216834190703574,0.0525812935314674,-0.105227677228712,0.10089099341464,0.967106663096288
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X2139.Age first had sexual intercourse,45832,0.00384560305222371,0.00193740359633342,4.82920034102093e-05,0.00764291410103721,0.0471685188320522
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X2149.Lifetime number of sexual partners,44414,-0.0196215553674201,0.0599611678607012,-0.137145444374394,0.0979023336395542,0.74349243139635
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X22032.IPAQ activity group,45142,-0.0295967147574938,0.0555984499198778,-0.138569676600454,0.0793762470854666,0.594504708609589
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X22033.Summed days activity,45466,-0.00158428202904499,0.00194464865233618,-0.00539579338762389,0.00222722932953392,0.415262395189315
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X22034.Summed minutes activity,45142,-0.00344109658275993,0.00196293405896474,-0.00728844733833082,0.000406254172810947,0.0796141302995139
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X22037.MET minutes per week for walking,44548,-0.00492660551706516,0.00201623202160566,-0.00887842027941225,-0.000974790754718079,0.0145574828745648
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X22038.MET minutes per week for moderate activity,45142,-0.0031492506177328,0.00199423017500977,-0.00705794176075196,0.000759440525286357,0.114313642235431
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X22039.MET minutes per week for vigorous activity,45142,0.0387319523160315,0.0557736599196504,-0.0705844211264833,0.148048325758546,0.487410539942106
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X22040.Summed MET minutes per week for all activity,44548,-0.00222769737278157,0.00199327100579272,-0.00613450854413529,0.00167911379857215,0.263750910855061
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X2217.Age started wearing glasses or contact lenses,45211,-0.00238875436702191,0.00202209018283516,-0.00635205112537883,0.00157454239133501,0.237488847346229
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X22501.Year ended full time education,33168,0.00574776840093747,0.00905849285385437,-0.0120068775926171,0.023502414394492,0.525775201665515
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X22506.Tobacco smoking,33135,0.0893626665645482,0.202162652860513,-0.306876133042058,0.485601466171154,0.65848604602327
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,47179,-0.0482307853754837,0.158461921615886,-0.358816151742621,0.262354580991653,0.76085072639607
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23098.Weight,47957,0.00612562549241102,0.00480071725889757,-0.00328378033502821,0.0155350313198503,0.201977436661227
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23099.Body fat percentage,47927,-0.0044265450757655,0.00428366033332038,-0.0128225193290734,0.00396942917754244,0.301450372087428
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23100.Whole body fat mass,47890,-0.0025788254049484,0.00428725480231408,-0.010981844817484,0.00582419400758719,0.547507613195988
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23101.Whole body fat-free mass,47952,0.00585946126175359,0.00414697344894825,-0.00226860669818499,0.0139875292216922,0.157686854372747
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23102.Whole body water mass,47957,0.00629019765037682,0.00413522737549278,-0.00181484800558902,0.0143952433063427,0.128244811381444
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23104.Body mass index (BMI),47957,0.00102940320896633,0.00972838794012463,-0.0180382371536779,0.0200970435716106,0.915730734250867
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23105.Basal metabolic rate,47957,0.00622085682440044,0.00430636784727091,-0.00221962415625055,0.0146613378050514,0.148594432184647
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23106.Impedance of whole body,47957,-0.00395034102406381,0.00338708416726271,-0.0105890259918987,0.00268834394377109,0.243509360831099
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23107.Impedance of leg (right),47957,-0.000165024961377793,0.00274952628129237,-0.00555409647271083,0.00522404654995525,0.952140790520233
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23108.Impedance of leg (left),47957,-0.00117899891740444,0.00273245813563688,-0.00653461686325273,0.00417661902844385,0.666124760863204
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23109.Impedance of arm (right),47957,-0.00274295969038457,0.00335757693470923,-0.00932381048241466,0.00383789110164551,0.413969232915941
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23110.Impedance of arm (left),47957,-0.00340736657791855,0.00335057584435671,-0.0099744952328577,0.00315976207702059,0.309190142892438
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23111.Leg fat percentage (right),47957,-0.000406755563425817,0.00436655104994125,-0.00896519562131066,0.00815168449445903,0.925783297980385
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23112.Leg fat mass (right),47957,-0.00140336246311743,0.00470010398226838,-0.0106155662683635,0.0078088413421286,0.765262853068234
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23113.Leg fat-free mass (right),47956,0.00178215094540692,0.0045587281981999,-0.00715295632306489,0.0107172582138787,0.695852092240436
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23114.Leg predicted mass (right),47956,0.00170347482712293,0.00459197963182286,-0.00729680525124987,0.0107037549054957,0.710665859518044
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23115.Leg fat percentage (left),47956,-0.00227350397254576,0.0045560090591041,-0.0112032817283898,0.00665627378329828,0.61777648077724
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23116.Leg fat mass (left),47956,-0.00292548694268804,0.00496980835054109,-0.0126663113097486,0.00681533742437251,0.556101704500661
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23117.Leg fat-free mass (left),47955,0.00313913105846563,0.00495130744040064,-0.00656543152471963,0.0128436936416509,0.526088032322599
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23118.Leg predicted mass (left),47955,0.00314594361212206,0.00499039415642107,-0.00663522893446323,0.0129271161587074,0.528440466706054
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23119.Arm fat percentage (right),47955,-0.00250273432095048,0.00481196000345599,-0.0119341759277242,0.00692870728582327,0.602994913679966
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23120.Arm fat mass (right),47954,0.00353495596708012,0.00527079354698415,-0.00679579938500881,0.0138657113191691,0.502439644509152
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23121.Arm fat-free mass (right),47953,0.0071533128876926,0.00454069687997634,-0.00174645299706102,0.0160530787724462,0.115185619908762
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23122.Arm predicted mass (right),47953,0.00676980363930327,0.00456544421343871,-0.00217846701903659,0.0157180742976431,0.138134353390886
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23123.Arm fat percentage (left),47951,-0.00360074298139199,0.00452625074883235,-0.0124721944491034,0.00527070848631942,0.426318272061865
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23124.Arm fat mass (left),47951,0.00252219362922879,0.00505429024432463,-0.00738421524964749,0.0124286025081051,0.617770728581885
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23125.Arm fat-free mass (left),47947,0.00764150378981212,0.00413585655778941,-0.000464775063455114,0.0157477826430794,0.0646721518539283
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23126.Arm predicted mass (left),47946,0.0072482281429316,0.00415839626608269,-0.000902228538590466,0.0153986848244537,0.0813434764883525
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23127.Trunk fat percentage,47945,-0.00454311539969755,0.00362683025639497,-0.0116517027022317,0.00256547190283659,0.210351617090469
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23128.Trunk fat mass,47945,-0.00168588539668077,0.00382550722481356,-0.00918387955731535,0.00581210876395381,0.659438080669996
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23129.Trunk fat-free mass,47944,0.00632376111303024,0.00359865208221537,-0.000729596968111892,0.0133771191941724,0.0788896154941298
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23130.Trunk predicted mass,47942,0.00608374411618299,0.00359923884735383,-0.000970764024630516,0.0131382522569965,0.0909893082337259
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23400.Total Cholesterol,39560,0.00295154316811555,0.00258924913639905,-0.00212338513922659,0.0080264714754577,0.254343530076551
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,39560,0.00255799313626379,0.0025268399191094,-0.00239461310519064,0.00751059937771821,0.311403157337357
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",39560,0.00174515426336695,0.00253965599217388,-0.00323257148129385,0.00672288000802775,0.491995392443852
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23403.VLDL Cholesterol,39560,0.000407471838055156,0.0026095506457353,-0.00470724742758602,0.00552219110369634,0.875920531283563
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23404.Clinical LDL Cholesterol,39560,0.00330163589812906,0.00251857194734839,-0.00163476511867378,0.00823803691493189,0.189913659576616
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23405.LDL Cholesterol,39560,0.00311906353354116,0.00250746290723032,-0.00179556376463026,0.00803369083171258,0.213558506705638
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23406.HDL Cholesterol,39560,0.0026424367364536,0.00285946243656059,-0.00296210963920516,0.00824698311211235,0.355453232500711
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23407.Total Triglycerides,39560,-0.00205340757698348,0.00264129040698563,-0.00723033677467531,0.00312352162070835,0.436924315438862
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23408.Triglycerides in VLDL,39560,-0.00171190258837052,0.00267803694588282,-0.00696085500230084,0.0035370498255598,0.52268156990783
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23409.Triglycerides in LDL,39560,-0.00288896721792193,0.00250164779727889,-0.00779219690058855,0.00201426246474469,0.248186980022863
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23410.Triglycerides in HDL,39560,-0.00457249976973435,0.00258322369414091,-0.00963561821025054,0.00049061867078184,0.0767424381614968
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,39560,0.00111559782940143,0.00260028028760244,-0.00398095153429935,0.00621214719310222,0.667909943379987
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23412.Phospholipids in VLDL,39560,-0.000575758015563611,0.00263172879853417,-0.00573394646069059,0.00458243042956336,0.826828937681531
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23413.Phospholipids in LDL,39560,0.00274933900481288,0.00251720668677908,-0.00218438610127412,0.00768306411089988,0.27476120398901
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23414.Phospholipids in HDL,39560,0.000444929976811347,0.00272856175747067,-0.00490305106783117,0.00579291102145387,0.870471113387006
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23415.Total Esterified Cholesterol,39560,0.00306352761112285,0.00260319555455895,-0.0020387356758127,0.00816579089805839,0.239287545154616
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,39560,0.000736015703940149,0.00259734138563433,-0.00435477341190314,0.00582680481978344,0.776896486994214
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23417.Cholesteryl Esters in LDL,39560,0.00284755229183272,0.0025072677554669,-0.0020666925088824,0.00776179709254785,0.256098909470899
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23418.Cholesteryl Esters in HDL,39560,0.00284229357588974,0.00285992295397328,-0.0027631554138979,0.00844774256567737,0.320324795581578
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23419.Total Free Cholesterol,39560,0.00259083397757358,0.00255684981134941,-0.00242059165267127,0.00760225960781842,0.310943352831341
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23420.Free Cholesterol in VLDL,39560,-5.47946226230311e-05,0.00262323520677635,-0.00519633562790468,0.00508674638265862,0.983335231716315
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23421.Free Cholesterol in LDL,39560,0.00374453830763514,0.00251856018895806,-0.00119183966272266,0.00868091627799294,0.137102384591903
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23422.Free Cholesterol in HDL,39560,0.00175005708262614,0.00284099508430443,-0.00381829328261055,0.00731840744786283,0.537906357306097
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,39560,0.00110201813355201,0.00249887573870607,-0.00379577831431189,0.00599981458141591,0.659217659270602
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23424.Total Lipids in VLDL,39560,-0.000890348780905893,0.00263038490555015,-0.00604590319578419,0.0042652056339724,0.73500336894107
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23425.Total Lipids in LDL,39560,0.0027032219145937,0.00250931095977974,-0.00221502756657458,0.00762147139576199,0.281380435003685
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23426.Total Lipids in HDL,39560,0.000950306916190524,0.0027777001715564,-0.00449398542006002,0.00639459925244106,0.732267110540552
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,39560,0.00160113460697444,0.00264496102345338,-0.00358298899899419,0.00678525821294307,0.5449571283017
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23428.Concentration of VLDL Particles,39560,-0.000243471645106842,0.00260073910767115,-0.00534092029614229,0.00485397700592861,0.92541564999023
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23429.Concentration of LDL Particles,39560,0.00245313067135167,0.00251810277601463,-0.00248235076963701,0.00738861211234034,0.329979741247163
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23430.Concentration of HDL Particles,39560,0.00140789052693022,0.00264456595314796,-0.00377545874123977,0.00659123979510022,0.594479778366719
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23431.Average Diameter for VLDL Particles,39560,-0.000832250052261371,0.00271515834944251,-0.00615396041716868,0.00448946031264594,0.759214656960682
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23432.Average Diameter for LDL Particles,39560,0.00781678075718092,0.00258616043817582,0.00274790629835632,0.0128856552160055,0.0025123969807061
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23433.Average Diameter for HDL Particles,39560,0.000542096858451286,0.00284369653738538,-0.00503154835482406,0.00611574207172663,0.848818192205254
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23434.Phosphoglycerides,39550,0.000451584395114888,0.0026039496411881,-0.0046521569016138,0.00555532569184357,0.86232226291582
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,39550,-0.00319165480687548,0.00278330982672342,-0.00864694206725337,0.00226363245350242,0.251525721102276
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23436.Total Cholines,39550,0.00114202101235571,0.00265045275549424,-0.004052866388413,0.00633690841312442,0.666565773212699
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23437.Phosphatidylcholines,39550,0.00139257767550649,0.00265816917933735,-0.00381743391599472,0.0066025892670077,0.600368420809019
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23438.Sphingomyelins,39550,0.00375035419950549,0.00267722392765171,-0.00149700469869187,0.00899771309770285,0.161291174190984
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23439.Apolipoprotein B,39560,0.00209130122272795,0.00252896876091878,-0.00286547754867287,0.00704807999412877,0.408290015247538
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23440.Apolipoprotein A1,39560,0.000765892679053337,0.00271985994387974,-0.00456503281095095,0.00609681816905762,0.778261161994065
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,39560,0.00155067001796571,0.00256878825549638,-0.00348415496280719,0.0065854949987386,0.546083422929939
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23442.Total Fatty Acids,39550,-0.00147248193448973,0.00242934011301316,-0.00623398855599552,0.00328902468701605,0.544444818598841
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23443.Degree of Unsaturation,39550,0.00298950022366956,0.00261426224562268,-0.0021344537777509,0.00811345422509002,0.252841554894272
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23444.Omega-3 Fatty Acids,39550,-0.000694228082918514,0.00254721853692462,-0.00568677641529077,0.00429832024945374,0.785209218880569
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23445.Omega-6 Fatty Acids,39550,0.000905702517502627,0.00251461884449369,-0.004022950417705,0.00583435545271025,0.718723312245521
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,39550,0.000801159628381624,0.00252632896829769,-0.00415044514948185,0.0057527644062451,0.751155536459156
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23447.Monounsaturated Fatty Acids,39550,-0.00296821363155607,0.00247005998126437,-0.00780953119483422,0.00187310393172209,0.229514784077382
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23448.Saturated Fatty Acids,39550,-0.00166752368703133,0.00239646844850315,-0.00636460184609751,0.00302955447203485,0.486552929446074
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23449.Linoleic Acid,39550,0.000769294779378592,0.0025102116083954,-0.00415071997307638,0.00568930953183357,0.759255608668008
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23450.Docosahexaenoic Acid,39550,0.00308908324396973,0.00252854602199459,-0.00186686695913968,0.00804503344707913,0.221853594986244
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,39550,-1.19510822504796e-05,0.00255242334075282,-0.00501470083012601,0.00499079866562505,0.996264204565539
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,39550,0.00383123457657563,0.00249608373452131,-0.00106108954308614,0.00872355869623741,0.124837712880071
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,39550,0.00404667348449421,0.00255637100216203,-0.00096381367974337,0.00905716064873178,0.113455855349063
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,39550,-0.00540771965150099,0.00269680284251838,-0.010693453222837,-0.000121986080164971,0.0449626442819326
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,39550,-0.00168970047362898,0.00233466346001196,-0.00626564085525243,0.00288623990799447,0.469237901618926
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,39550,0.00350742351969274,0.00255446371656037,-0.00149932536476559,0.00851417240415108,0.169762836471762
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,39550,0.00393210636684471,0.00249733588326959,-0.000962671964363689,0.0088268846980531,0.115396072124189
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,39550,0.00523796123399778,0.00266363349879872,1.7239576352291e-05,0.0104586828916433,0.0492693087923433
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,39550,0.00138906717293045,0.00251935163221302,-0.00354886202620707,0.00632699637206798,0.581398857323793
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23460.Alanine,39557,7.10326337230862e-05,0.0025153788556935,-0.00485910992343617,0.00500117519088234,0.977471776824972
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23461.Glutamine,39523,0.00469508734079637,0.00247391944783684,-0.000153794776963841,0.00954396945855658,0.0577443514951018
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23462.Glycine,39547,0.00375698271925066,0.00299344689785058,-0.00211017320053648,0.0096241386390378,0.209480466532575
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23463.Histidine,39546,0.00533747299314983,0.00248855919571521,0.000459896969548016,0.0102150490167516,0.0319904250664743
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),39550,0.00262976509004154,0.00279269141304321,-0.00284391007952315,0.00810344025960623,0.346387643292647
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23465.Isoleucine,39558,0.003379013664305,0.00269379828385813,-0.00190083097205693,0.00865885830066693,0.209735127958452
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23466.Leucine,39558,0.00333418149439065,0.00275715085922238,-0.00206983418968522,0.00873819717846652,0.226579417147299
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23467.Valine,39550,0.0017305529082783,0.0027831257190605,-0.00372437350108029,0.00718547931763688,0.53408507087927
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23468.Phenylalanine,39553,0.00563003717291604,0.00254900964065401,0.000633978277234168,0.0106260960685979,0.0272150616065946
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23469.Tyrosine,39548,0.0033235914086629,0.00266044611888421,-0.00189088298435015,0.00853806580167595,0.211596359131372
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23470.Glucose,39542,0.00604849532052405,0.0024269304504954,0.00129171163755307,0.010805279003495,0.0127086708331249
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23471.Lactate,39545,-0.000614018088392154,0.00255851072925002,-0.0056286991177222,0.00440066294093789,0.810342170444029
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23472.Pyruvate,39520,0.0006428455813221,0.00245224993021101,-0.00416356428189147,0.00544925544453567,0.793214434621856
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23473.Citrate,39558,0.00515357779686948,0.00252651428571719,0.000201609796863797,0.0101055457968752,0.0413944198205202
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23474.3-Hydroxybutyrate,39332,0.000265504190320123,0.00280622958188545,-0.00523470579017536,0.00576571417081561,0.924624445440669
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23475.Acetate,39549,0.0050004852628882,0.00239737915775936,0.000301622113679859,0.00969934841209654,0.0370186342329973
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23476.Acetoacetate,39559,-0.00278182783590027,0.00255199142772434,-0.00778373103423998,0.00222007536243945,0.275709981496937
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23477.Acetone,39559,0.00300061677217643,0.00252125444314746,-0.00194104193639258,0.00794227548074544,0.234021670206986
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23478.Creatinine,39356,0.00158387689217991,0.00310126729339994,-0.00449460700288397,0.00766236078724379,0.609558144037077
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23479.Albumin,39558,0.00431529774856735,0.00251485709831062,-0.000613822164121466,0.00924441766125616,0.0862046487604535
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23480.Glycoprotein Acetyls,39560,-0.00179956439714788,0.0026225846538718,-0.00693983031873662,0.00334070152444085,0.492614301371817
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,39560,-0.00360745122665191,0.00265695392777401,-0.00881508092508897,0.00160017847178515,0.174574319238075
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,39560,-0.00363835761089357,0.00264011538005555,-0.00881298375580244,0.0015362685340153,0.168198840769271
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,39560,-0.00431046021484653,0.00273012106416445,-0.00966149750060885,0.00104057707091579,0.114398605146272
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,39560,-0.00401482963904984,0.00268530068826097,-0.00927801898804135,0.00124835970994166,0.134913582210153
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,39560,-0.00376928961681835,0.00268384276871503,-0.0090296214434998,0.00149104220986311,0.160216927562218
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,39560,-0.00418392656105489,0.00266734520095952,-0.00941192315493554,0.00104407003282576,0.116776257840485
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,39560,-0.0035453143061039,0.00258891781412768,-0.00861959322179415,0.00152896460958636,0.170896268656136
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,39560,-0.00163408988450645,0.00276287683343517,-0.00704932847803938,0.00378114870902648,0.554234447099448
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,39560,-0.00139778617926157,0.00274439038424604,-0.00677679133238381,0.00398121897386067,0.610534806981007
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,39560,-0.00161760066628066,0.00274312300059466,-0.00699412174744619,0.00375892041488487,0.555408587492232
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,39560,-0.000726288648541284,0.00273017698991026,-0.0060774355487654,0.00462485825168283,0.790226845056053
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,39560,5.86969997617705e-05,0.00272966667240665,-0.00529144967815526,0.0054088436776788,0.982844516207456
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,39560,-0.00141558190635107,0.00272234082544427,-0.00675136992422184,0.0039202061115197,0.603083120779088
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,39560,-0.00167075089370033,0.00275048726075999,-0.00706170592478991,0.00372020413738924,0.543572761550536
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23495.Concentration of Large VLDL Particles,39560,-0.000745839158742389,0.00272192974629366,-0.00608082146147797,0.00458914314399319,0.784081200247263
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23496.Total Lipids in Large VLDL,39560,3.35566507624966e-05,0.00271275022883846,-0.00528343379776088,0.00535054709928587,0.990130665292937
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23497.Phospholipids in Large VLDL,39560,-0.000783607910581408,0.00276787167770275,-0.00620863639887881,0.00464142057771599,0.777099037269862
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23498.Cholesterol in Large VLDL,39560,-3.15755940384294e-05,0.00273763260681674,-0.00539733550339923,0.00533418431532237,0.990797689348465
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,39560,0.000580373979808712,0.00271902030432494,-0.00474890581666816,0.00590965377628559,0.830980214176158
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,39560,-0.00061067009551298,0.00276057384034846,-0.00602139482259597,0.00480005463157001,0.824932041146971
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23501.Triglycerides in Large VLDL,39560,0.000265040815548765,0.0026700238178261,-0.00496820586739039,0.00549828749848792,0.920929414514879
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,39560,0.00160661175480735,0.0025781333130175,-0.00344652953870696,0.00665975304832165,0.533186693505409
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23503.Total Lipids in Medium VLDL,39560,0.00155359315472742,0.00258200529994414,-0.00350713723316309,0.00661432354261793,0.547386149768485
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23504.Phospholipids in Medium VLDL,39560,0.00175124469629033,0.00257359609229414,-0.00329300364460618,0.00679549303718683,0.49622380282999
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23505.Cholesterol in Medium VLDL,39560,0.00284653131840823,0.00252990774516289,-0.00211208786211104,0.0078051504989275,0.260549174616836
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,39560,0.00326321114155765,0.00252071881916824,-0.00167739774401211,0.00820382002712741,0.195500784936437
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,39560,0.00216886399598835,0.00256008044521163,-0.00284889367662644,0.00718662166860314,0.396910023170302
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23508.Triglycerides in Medium VLDL,39560,0.000399233524339177,0.00264321332387397,-0.0047814645904538,0.00557993163913215,0.879946170986823
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23509.Concentration of Small VLDL Particles,39560,-0.000775855742474753,0.00265638473708131,-0.00598236982715412,0.00443065834220462,0.770237062518803
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23510.Total Lipids in Small VLDL,39560,-0.000583216751085093,0.0026600801978436,-0.00579697393885855,0.00463054043668837,0.826461099053735
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23511.Phospholipids in Small VLDL,39560,0.000788980322985034,0.00261294926157079,-0.00433240022969372,0.00591036087566379,0.762695822668274
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23512.Cholesterol in Small VLDL,39560,0.000611765885685443,0.00263628834216604,-0.00455535926496,0.00577889103633089,0.816499040614059
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,39560,-9.61905814508265e-05,0.00268163785800082,-0.00535220078313243,0.00515981962023078,0.971386601412839
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,39560,0.0017626082316137,0.00256603052311609,-0.00326681159369384,0.00679202805692124,0.492159821910218
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23515.Triglycerides in Small VLDL,39560,-0.00245235405995765,0.00267810151481877,-0.00770143302900243,0.00279672490908714,0.359841178767334
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,39560,-0.000536382181554058,0.00255127973076425,-0.00553689045385199,0.00446412609074388,0.833483923801227
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,39560,-0.000268624495948272,0.00256609037411036,-0.00529816162920458,0.00476091263730804,0.916629744465905
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,39560,-0.000378224657788126,0.00255485416588157,-0.005385738822916,0.00462928950733975,0.882312673808116
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,39560,0.00130239897002017,0.00258495169579003,-0.00376410635372829,0.00636890429376863,0.614384784095808
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,39560,0.0017058694577097,0.00260348977034223,-0.00339697049216107,0.00680870940758047,0.512337178194315
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,39560,0.000426409668690431,0.00256000935638368,-0.00459120866982158,0.00544402800720244,0.867714881802757
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,39560,-0.00359138375351045,0.00260383481372636,-0.00869489998841411,0.00151213248139321,0.167840551843405
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23523.Concentration of IDL Particles,39560,0.00171523576662846,0.00253520237625544,-0.0032537608908322,0.00668423242408913,0.498694624735792
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23524.Total Lipids in IDL,39560,0.00281446831965707,0.00259240279218747,-0.00226664115303037,0.00789557779234451,0.27765326990912
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23525.Phospholipids in IDL,39560,0.00279182744275233,0.00258866653551754,-0.00228195896686205,0.00786561385236671,0.280842930926906
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23526.Cholesterol in IDL,39560,0.00340178192838382,0.00260438498656923,-0.00170281264529187,0.00850637650205952,0.191520546194891
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23527.Cholesteryl Esters in IDL,39560,0.00366500089772224,0.0026090430024949,-0.00144872338716776,0.00877872518261225,0.16012993020069
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23528.Free Cholesterol in IDL,39560,0.00250736816247636,0.00258150089999921,-0.00255237360152208,0.00756710992647481,0.331428763147844
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23529.Triglycerides in IDL,39560,-0.00302828691744745,0.00252071566901381,-0.00796888962871452,0.00191231579381962,0.229637554139966
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23530.Concentration of Large LDL Particles,39560,0.00350692419293243,0.00250593505106873,-0.00140470850716229,0.00841855689302714,0.161707174544406
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23531.Total Lipids in Large LDL,39560,0.00317194391973614,0.00252191804975514,-0.00177101545778394,0.00811490329725622,0.208508766283159
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23532.Phospholipids in Large LDL,39560,0.00296853289081869,0.00252911187911261,-0.00198852639224201,0.0079255921738794,0.240522610770919
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23533.Cholesterol in Large LDL,39560,0.0036479515096682,0.00252177192184268,-0.00129472145714346,0.00859062447647986,0.14804244568538
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,39560,0.00354759278616929,0.00251776827295464,-0.00138723302882179,0.00848241860116038,0.158856810070633
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23535.Free Cholesterol in Large LDL,39560,0.00384289706802194,0.00254239546238842,-0.00114019803825936,0.00882599217430325,0.130683297728951
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23536.Triglycerides in Large LDL,39560,-0.00274968826024489,0.00249834270316997,-0.00764643995845804,0.00214706343796826,0.271092816861759
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23537.Concentration of Medium LDL Particles,39560,0.000568801543734613,0.00253432057221459,-0.00439846677780599,0.00553606986527521,0.822419551957017
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23538.Total Lipids in Medium LDL,39560,0.00184702326953097,0.00251891102789106,-0.00309004234513552,0.00678408888419745,0.463413959377068
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23539.Phospholipids in Medium LDL,39560,0.00219279301467322,0.002527650079663,-0.00276140114146626,0.00714698717081271,0.385674847741584
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23540.Cholesterol in Medium LDL,39560,0.00210295253847458,0.00251430879774702,-0.00282509270510957,0.00703099778205874,0.402951578519924
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,39560,0.00160861118760669,0.0025238137760503,-0.00333806381345188,0.00655528618866527,0.523895113994371
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,39560,0.00331982793747956,0.00249944351205921,-0.0015790813461565,0.00821873722111562,0.184130840203862
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23543.Triglycerides in Medium LDL,39560,-0.00287552252670038,0.00251508570738389,-0.00780509051317281,0.00205404545977205,0.252934895334526
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23544.Concentration of Small LDL Particles,39560,0.000878447997020291,0.0025355305729278,-0.00409119192591819,0.00584808791995877,0.729007225172228
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23545.Total Lipids in Small LDL,39560,0.00195411873967946,0.00250148562770412,-0.00294879309062062,0.00685703056997953,0.434711581023529
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23546.Phospholipids in Small LDL,39560,0.00269429386802158,0.00249256788730746,-0.00219113919110103,0.00757972692714419,0.279751597120182
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23547.Cholesterol in Small LDL,39560,0.00219534184331206,0.00250706284113564,-0.00271850132531379,0.00710918501193791,0.381232526034117
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,39560,0.00143599105235762,0.0025099880468904,-0.00348358551954756,0.00635556762426281,0.567258705323728
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23549.Free Cholesterol in Small LDL,39560,0.00401478333052564,0.00250028337841346,-0.000885772091164751,0.00891533875221602,0.108361766044969
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23550.Triglycerides in Small LDL,39560,-0.00324583489697412,0.00254018083128194,-0.00822458932628673,0.00173291953233849,0.201348152060577
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,39560,0.000697703441323143,0.00289240941392341,-0.00497141900996674,0.00636682589261303,0.809390076310028
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23552.Total Lipids in Very Large HDL,39560,0.00101750995644529,0.00289933410824368,-0.00466518489571232,0.00670020480860291,0.72563554156128
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23553.Phospholipids in Very Large HDL,39560,0.000745266323738859,0.00288213691266321,-0.00490372202508104,0.00639425467255876,0.795963272089183
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23554.Cholesterol in Very Large HDL,39560,0.00212420683367521,0.00293818566865692,-0.00363463707689236,0.00788305074424277,0.469716515370576
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,39560,0.00224853851891771,0.00295677652044747,-0.00354674346115932,0.00804382049899475,0.446990321098485
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,39560,0.00185007216133591,0.00284745371424187,-0.00373093711857816,0.00743108144124998,0.515881152697731
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23557.Triglycerides in Very Large HDL,39560,-0.00379421722118491,0.00241720379763038,-0.00853193666454047,0.000943502222170638,0.116520296345049
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23558.Concentration of Large HDL Particles,39560,0.00155365660661364,0.00293050093442479,-0.00419012522485894,0.00729743843808622,0.596006482837722
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23559.Total Lipids in Large HDL,39560,0.00163064270462371,0.00290351166222684,-0.00406024015334089,0.00732152556258831,0.574392892231593
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23560.Phospholipids in Large HDL,39560,0.00141856411291262,0.00287137980166178,-0.00420934029834446,0.0070464685241697,0.621290872181811
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23561.Cholesterol in Large HDL,39560,0.0023624125973066,0.0029511948411364,-0.00342192929132073,0.00814675448593394,0.423442218334826
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,39560,0.00255784713826544,0.00296222620529683,-0.00324811622411636,0.00836381050064723,0.387888043647596
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23563.Free Cholesterol in Large HDL,39560,0.00174826033501898,0.0029116149083463,-0.00395850488533978,0.00745502555537774,0.548223099531329
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23564.Triglycerides in Large HDL,39560,-0.00474115672531097,0.00253481842103083,-0.00970940083053139,0.000227087379909444,0.0614531528110353
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23565.Concentration of Medium HDL Particles,39560,0.000486037688814695,0.00268668709897713,-0.00477986902518048,0.00575194440280987,0.856444741496404
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23566.Total Lipids in Medium HDL,39560,0.000141771567944727,0.00264054936933897,-0.00503370519595965,0.0053172483318491,0.9571829861975
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23567.Phospholipids in Medium HDL,39560,-0.000304146713232753,0.00259377332916893,-0.00538794243840386,0.00477964901193835,0.9066559098083
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23568.Cholesterol in Medium HDL,39560,0.00146910157826391,0.00271875453941113,-0.0038596573189819,0.00679786047550972,0.588960940376561
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,39560,0.00148728899165985,0.00271383363818385,-0.0038318249391805,0.00680640292250019,0.583675698836435
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,39560,0.00128705073061958,0.0027327234801082,-0.00406908729039249,0.00664318875163165,0.637666317792506
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23571.Triglycerides in Medium HDL,39560,-0.00443928900300664,0.00261045342745905,-0.00955577772082637,0.000677199714813094,0.0890499557116284
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23572.Concentration of Small HDL Particles,39560,0.00123306814775612,0.00251680142172762,-0.00369986263883001,0.00616599893434225,0.624189970667539
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23573.Total Lipids in Small HDL,39560,-3.27158257762693e-05,0.0025177895006731,-0.00496758324709554,0.004902151595543,0.989632921151806
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23574.Phospholipids in Small HDL,39560,-0.00027273871140705,0.00250441640930638,-0.00518139487364755,0.00463591745083345,0.913281341246044
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23575.Cholesterol in Small HDL,39560,0.00152272402233229,0.00250346762198495,-0.00338407251675822,0.00642952056142279,0.543036972418117
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,39560,0.00178209854372914,0.00251175671279357,-0.00314094461334625,0.00670514170080453,0.478027577237909
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23577.Free Cholesterol in Small HDL,39560,0.00044517935578027,0.00250395814866145,-0.00446257861559617,0.00535293732715671,0.858890987095518
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23578.Triglycerides in Small HDL,39560,-0.00444534825866196,0.00281230928009524,-0.00995747444764863,0.00106677793032472,0.113981119121331
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39241,-0.00495847043325773,0.00281953126504044,-0.010484751712737,0.000567810846221545,0.0786716371156992
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39241,0.0036866226795018,0.00270730004934131,-0.00161968541720717,0.00899293077621078,0.173310657616155
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39241,0.00438331346552208,0.00274184234207195,-0.000990697524938946,0.00975732445598311,0.109922633904155
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39241,0.000607413554853441,0.00269844966266567,-0.00468154778397128,0.00589637489367816,0.821907955213322
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39241,-0.00148281071721046,0.002744070123078,-0.00686118815844333,0.00389556672402241,0.588953818851134
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,39500,-0.000924447416814648,0.00275805852675323,-0.00633024212925098,0.00448134729562169,0.737495386267837
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,39500,0.00219691227721781,0.00279358064008181,-0.00327850577734254,0.00767233033177817,0.431641797065958
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,39500,0.00282362864141744,0.00277944969657669,-0.00262409276387288,0.00827135004670776,0.309702008655444
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,39500,5.85003292501975e-05,0.00279545577134532,-0.00542059298258663,0.00553759364108703,0.983304321057184
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,39500,-0.00189784149625241,0.00278743495931927,-0.00736121401651818,0.00356553102401335,0.495977147142177
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,39560,-0.00565559027635183,0.00289323458114609,-0.0113263300553982,1.51495026944979e-05,0.0506363389645231
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,39560,-0.000230648103250384,0.00269623999950084,-0.00551527850227203,0.00505398229577126,0.931830199523392
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,39560,0.000907459444625438,0.0027407087958257,-0.00446432979519293,0.00627924868444381,0.740572315546609
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,39560,-0.00361670800296176,0.00273536657115261,-0.00897802648242089,0.00174461047649736,0.186128383885664
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,39560,0.00159946992570626,0.00275083222994305,-0.00379216124498211,0.00699110109639463,0.560949526105459
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,39560,0.00136308087615009,0.00265535103391281,-0.00384140715031901,0.00656756890261919,0.607728339178675
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,39560,0.00250355413124725,0.00274657339110517,-0.00287972971531888,0.00788683797781338,0.362041969235158
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,39560,0.00252687227525033,0.00276128743043628,-0.00288525108840478,0.00793899563890543,0.360155817547166
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,39560,0.00213057521157973,0.00268818567330007,-0.0031382687080884,0.00739941913124786,0.428045571559062
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,39560,-0.00235342932647638,0.00272341058998885,-0.00769131408285453,0.00298445542990177,0.387525603441951
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,39560,0.00503822265076122,0.00268172187366477,-0.000217952221621726,0.0102943975231442,0.0603083307574674
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,39560,0.00314538123699745,0.00258980510684572,-0.00193063677242016,0.00822139924641506,0.224573742402777
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,39560,0.00147592711437663,0.00254785880557119,-0.00351787614454291,0.00646973037329616,0.562411246234965
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,39560,0.00503230103820369,0.00270566462870957,-0.000270801634067059,0.0103354037104744,0.0629245950133291
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,39560,-0.00374945651626212,0.00261596401032336,-0.0088767459764959,0.00137783294397166,0.15180115981147
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,39560,-0.00119542767343027,0.00254130515092586,-0.00617638576924495,0.00378553042238442,0.638079262506749
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,39560,0.0046342994927217,0.00267379012116634,-0.00060632914476432,0.00987492813020772,0.0830825076076719
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,39560,0.00444323191790567,0.00270889889059357,-0.000866209907657733,0.00975267374346908,0.100984923619565
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,39560,0.0040773371902772,0.00236376200961996,-0.000555636348577919,0.00871031072913231,0.0845672746244846
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,39560,-0.00493700271180884,0.00263861931135214,-0.010108696562059,0.000234691138441362,0.0613640361840714
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,39560,-0.00075200760588999,0.00249553041571012,-0.00564324722068182,0.00413923200890184,0.763159592937496
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,39560,0.00441855674099845,0.00260186613711297,-0.000681100887742964,0.00951821436973987,0.0894934990717585
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,39560,0.00551397913174266,0.00257899528673572,0.000459148369740651,0.0105688098937447,0.0325360506970572
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,39560,-0.000111609502337097,0.00238742054394616,-0.00479095376847157,0.00456773476379738,0.962714135305288
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,39560,-0.00556883480329922,0.00261514525257961,-0.0106945194983553,-0.000443150108243187,0.0332388350664022
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,39560,-0.0032166202821274,0.00253253665753935,-0.00818039213090452,0.00174715156664972,0.204069579927108
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,39560,0.00795220231088069,0.00258472685488439,0.00288613767530728,0.0130182669464541,0.00209883611289643
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,39560,0.00662261434076206,0.00246090098475889,0.00179924841063464,0.0114459802708895,0.00713176200405665
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,39560,0.00362505280228382,0.0027712134972845,-0.00180652565239379,0.00905663125696144,0.190863348477715
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,39560,-0.00643490246851825,0.00254163324810727,-0.0114165036348085,-0.001453301302228,0.0113617799627358
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,39560,0.00265893405721435,0.00260116609703333,-0.00243935149297098,0.00775721960739969,0.30670479716514
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,39560,0.00435938131898621,0.00257122799852145,-0.000680225558115837,0.00939898819608825,0.0900190214542343
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,39560,-0.00092743832103538,0.00260045295929521,-0.006024326121254,0.00416944947918324,0.721364515060973
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,39560,0.00429734895249466,0.00267389243982069,-0.000943480229553885,0.0095381781345432,0.108050050326643
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,39560,-0.00612622859653876,0.00253380605698195,-0.0110924884682234,-0.00115996872485413,0.0156309900196603
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,39560,0.00283739287182096,0.00259843953995752,-0.00225554862649579,0.0079303343701377,0.274874545199484
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,39560,0.00275454728543111,0.00252319707643598,-0.00219091898438342,0.00770001355524564,0.274993681061561
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,39560,-0.00239995744654037,0.00257508068152873,-0.00744711558233668,0.00264720068925595,0.351360616803999
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,39560,0.00538095081091341,0.00254163518485446,0.000399345848598663,0.0103625557732282,0.034271991737034
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,39560,-0.00589182425975019,0.00258919429328407,-0.010966645074587,-0.000817003444913414,0.0228925614867112
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,39550,-0.00046370842398027,0.00274344249821728,-0.00584085572048613,0.00491343887252559,0.865780656648505
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,39550,0.00264757095593001,0.00238176385296362,-0.00202068619587868,0.0073158281077387,0.266334170561757
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,39550,0.00360798207691206,0.00222750494821144,-0.000757927621582354,0.00797389177540648,0.105316626685926
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,39550,0.000637476095539828,0.00285167113530589,-0.00495179932965971,0.00622675152073936,0.823115733080364
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,39550,-0.00445513677810498,0.00270090003788437,-0.00974890085235834,0.00083862729614838,0.0990737625263839
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,39560,-0.00264051535545569,0.00255524009729112,-0.00764878594614629,0.0023677552352349,0.301452318751927
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,39560,0.00577913703204244,0.00269757908930888,0.000491882016997027,0.0110663920470878,0.0321879359004008
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,39560,0.00543727579130362,0.00259580707637339,0.000349493921611777,0.0105250576609955,0.0362260978649444
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,39560,0.00303203364335819,0.00257132369192081,-0.0020077607928066,0.00807182807952297,0.238355174777657
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,39560,-0.00588313489753479,0.00259265509083206,-0.0109647388755656,-0.00080153091950395,0.023278284122325
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,39560,-0.00371067794584258,0.00276439922188442,-0.00912890042073606,0.00170754452905089,0.179523630684238
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,39560,0.00494843279645999,0.00275186823458361,-0.000445228943323879,0.0103420945362439,0.0721714842998659
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,39560,0.00440249356123553,0.00261022161433532,-0.000713540802861692,0.00951852792533275,0.0917018381868391
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,39560,0.00428558228266118,0.00288715849651555,-0.00137324837050929,0.00994441293583165,0.137742226166372
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,39560,-0.00548372037536207,0.00270878909745267,-0.0107929470063693,-0.000174493744354846,0.0429514043464652
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,39560,-0.00215712812103667,0.00250006096607973,-0.00705724761455295,0.0027429913724796,0.388249707745943
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,39560,0.00466344029679094,0.00248319228944962,-0.000203616590530322,0.0095304971841122,0.0604074087939925
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,39560,0.00423698541624582,0.00244265630774507,-0.00055062094693452,0.00902459177942615,0.0828431474952869
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,39560,0.00206094444577513,0.00267582042278015,-0.00318366358287396,0.00730555247442421,0.441191756957653
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,39560,-0.0051909721006662,0.0028157530440263,-0.0107098480669578,0.000327903865625354,0.0652762165829832
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,48131,0.00102313499300136,0.00212360212906985,-0.00313912517997555,0.00518539516597826,0.629958952091068
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,48131,0.000852230398310849,0.00206986247526116,-0.00320470005320102,0.00490916084982272,0.680539754738606
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,46763,-0.000816113092152239,0.00195941703871055,-0.00465657048802492,0.00302434430372044,0.677043154132944
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,46763,0.00153836830632188,0.00213673674510663,-0.00264963571408712,0.00572637232673088,0.471557931776726
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,46763,0.0015820650641814,0.00211228962688214,-0.0025580226045076,0.00572215273287039,0.453878280376942
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,46763,0.000702773513960858,0.00194340996788034,-0.00310631002308461,0.00451185705100632,0.717641145845671
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24009.Traffic intensity on the nearest road,48131,0.0467253416488208,0.110863321618891,-0.170566768724205,0.264017452021847,0.673418017088016
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24010.Inverse distance to the nearest road,48131,-0.000869216411028957,0.00186379059389361,-0.00452224597506043,0.00278381315300252,0.640955732330819
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24011.Traffic intensity on the nearest major road,48131,4.56070017124795e-05,0.00184460978097678,-0.00356982816900201,0.00366104217242697,0.980274988304824
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24012.Inverse distance to the nearest major road,48131,0.00032648204396157,0.00188775296947366,-0.0033735137762068,0.00402647786412994,0.862694533645459
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24013.Total traffic load on major roads,48131,0.0485145176424379,0.0776862023978936,-0.103750439057434,0.200779474342309,0.532310924045281
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24015.Sum of road length of major roads within 100m,48131,0.0343498272418769,0.0757436503765057,-0.114107727496074,0.182807381979828,0.650193004619313
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,48131,0.000799081931365937,0.00213474557738293,-0.0033850194003046,0.00498318326303647,0.708168935389479
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,48131,0.001021397999725,0.0021347817801742,-0.00316277428941643,0.00520557028886643,0.632331423469655
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,48131,0.00126819862407249,0.00210806154543725,-0.00286360200498452,0.00539999925312949,0.547450949425019
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,48094,0.00223870091125885,0.00205850684807767,-0.00179597251097339,0.00627337433349109,0.276813313122228
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24020.Average daytime sound level of noise pollution,48131,-1.60311186990839e-05,0.00185346419543842,-0.00364882094175839,0.00361675870436022,0.993099052616263
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24021.Average evening sound level of noise pollution,48131,-1.2243157543344e-05,0.00185374831346248,-0.0036455898519298,0.00362110353684311,0.994730444122846
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24022.Average night-time sound level of noise pollution,48131,-2.10961739563941e-05,0.00185343770179432,-0.00365383406947327,0.00361164172156048,0.990918641309445
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24023.Average 16-hour sound level of noise pollution,48131,-1.75218149665243e-05,0.0018536205906741,-0.00365061817268776,0.00361557454275471,0.992458004322822
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24024.Average 24-hour sound level of noise pollution,48131,-1.4872946628777e-05,0.00185368355963701,-0.00364809272351732,0.00361834683025976,0.993598359761761
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X2405.Number of children fathered,48115,-0.0150029759947552,0.0589683227239261,-0.13058088853365,0.10057493654414,0.799170437546513
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",45891,0.00041053824896176,0.00218351775880193,-0.00386915655829002,0.00469023305621355,0.850865606273875
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",45891,-0.00269445644779031,0.00196094341260077,-0.00653790553648781,0.0011489926409072,0.169440464342424
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,"X24502.Water percentage, buffer 1000m",45891,-0.000405982440218996,0.00197761788348732,-0.00428211349185414,0.00347014861141615,0.837349053564976
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,"X24503.Greenspace percentage, buffer 300m",45891,-2.08698728800289e-05,0.00204777335460691,-0.00403450564790957,0.00399276590214951,0.991868621448925
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",45891,-0.00229000579857102,0.00198286146925771,-0.00617641427831613,0.00159640268117409,0.248147527758894
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,"X24505.Water percentage, buffer 300m",45891,-0.00125173697047104,0.0019911851006557,-0.00515445976775621,0.00265098582681413,0.529593607173475
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",48192,0.000856167200339849,0.00209220689917009,-0.00324455832203353,0.00495689272271323,0.682384693296126
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,"X24507.Natural environment percentage, buffer 300m",48192,0.000414758970103073,0.00196160742287712,-0.00342999157873607,0.00425950951894222,0.832547459904294
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24508.Distance (Euclidean) to coast,48192,0.00262082733600104,0.00185550813648101,-0.00101596861150174,0.00625762328350381,0.157831029011821
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X2867.Age started smoking in former smokers,34399,0.0047113809000758,0.0033651547819187,-0.00188432247248485,0.0113070842726365,0.161552203354751
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",35487,-0.0578439569311872,0.1157731046975,-0.284759242138287,0.169071328275913,0.617350131948831
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,35488,0.0536175059209182,0.130493668600785,-0.20215008453662,0.309385096378456,0.681171811192005
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,35488,0.124047465405335,0.120325766825484,-0.111791037572613,0.359885968383283,0.302609766485708
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",35477,0.0929260245563364,0.121213202522384,-0.144651852387537,0.330503901500209,0.443326153333662
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X28739.Difficulty with standing for long periods,35491,0.0422835497248245,0.104656214121701,-0.16284262995371,0.247409729403359,0.686208123438244
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X28740.Difficulty with taking care of household responsibilities,35506,-0.051713542927445,0.12250059626639,-0.29181471160957,0.188387625754679,0.672929180464285
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X28741.Difficulty learning a new task,35469,-0.174512502623701,0.146591896709853,-0.461832620175014,0.112807614927611,0.233904888639003
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X28742.Difficulty with joining in community activities,35112,-0.0651250875128256,0.135625644664574,-0.33095135105539,0.200701176029739,0.631113627189643
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X28743.Difficulty with being emotionally affected by health problems,35464,-0.0592052590964017,0.118418201285884,-0.291304933616734,0.172894415423931,0.61711395405869
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,35514,-0.0285496218547348,0.155859979909187,-0.334035182476742,0.276935938767272,0.854666233762795
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,33909,-0.0703451595215003,0.111152367584079,-0.288203799986296,0.147513480943295,0.526844858834853
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X2897.Age stopped smoking,34390,-0.00293922440464893,0.0035473580094696,-0.00989204610320935,0.00401359729391148,0.407383521701523
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,34688,0.00662598883124588,0.00775444962942414,-0.00857273244242545,0.0218247101049172,0.392875085802879
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,34688,-0.00575322400220609,0.00871830640736065,-0.022841104560633,0.0113346565562208,0.509341966259974
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,34688,0.0262278471275677,0.0295246920747938,-0.0316405493390282,0.0840962435941635,0.374395130978355
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,34688,-0.0248366861981968,0.0296928062030742,-0.0830345863562222,0.0333612139598286,0.402932001516189
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,34688,0.0507697135853223,0.0355372232848114,-0.0188832440529081,0.120422671223553,0.153160530283463
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,34688,0.0118880246398924,0.0326489577095917,-0.0521039324709074,0.0758799817506922,0.71578365118336
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,34688,-0.00655800723568398,0.0133348536758901,-0.0326943204404285,0.0195783059690605,0.622882380390585
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,34688,0.020168648506314,0.0252757809758271,-0.0293718822063071,0.0697091792189351,0.424934323512453
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29002.Recent lack of interest or pleasure in doing things,34660,0.0355175844274412,0.121237380198942,-0.202107680762485,0.273142849617368,0.769563507180385
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29003.Recent feelings of depression,34662,-0.0350544129956457,0.121758984124493,-0.273702021879652,0.203593195888361,0.773433122883094
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",34663,0.000942347659926416,0.0951582386055691,-0.185567800006989,0.187452495326842,0.99209904096073
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29005.Recent feelings of tiredness or low energy,34664,-0.055187058931579,0.0959325208271671,-0.243214799752826,0.132840681889669,0.565130356860216
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29006.Recent poor appetite or overeating,34671,0.00399294802100423,0.146612984087036,-0.283368500789586,0.291354396831594,0.978273503441369
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29007.Recent feelings of inadequacy,34653,0.166009574964102,0.126954139814238,-0.0828205390718051,0.414839689000009,0.191047090413021
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29008.Recent trouble concentrating on things,34669,-0.0335589238384691,0.128475869995645,-0.285371629029932,0.218253781352994,0.793940982474306
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29009.Recent changes in speed or amount of moving or speaking,34665,-0.0889090306550531,0.223785115399238,-0.527527856837559,0.349709795527453,0.691162854352986
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29010.Recent thoughts of suicide or self-harm,34649,-0.102482276908617,0.24338156009612,-0.579510134697011,0.374545580879778,0.673714121870221
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29038#0.Substances taken for depression_None of options listed,34739,0.0122220944438702,0.0141806321698685,-0.0155719446090721,0.0400161334968124,0.388783681043325
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),34739,-0.00292994997601163,0.0254320100728026,-0.0527766897187047,0.0469167897666815,0.908284681441384
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),34739,-0.0127762621404962,0.0160858712217582,-0.0443045697351423,0.0187520454541499,0.427078474710867
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),34739,-0.0822024504351786,0.0487901103988682,-0.17783106681696,0.013426165946603,0.0920745425896088
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),34739,0.00510329853193033,0.0312709447184956,-0.0561877531163211,0.0663943501801817,0.870369350363125
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),34739,-0.0410223654078962,0.0381588004299311,-0.115813614250561,0.0337688834347688,0.282397560943925
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),34739,-0.0883550892165427,0.0381717781087086,-0.163171774309612,-0.0135384041234737,0.0206638005235344
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),34739,0.0379562943379602,0.0436829069357201,-0.0476622032560512,0.123574791931972,0.384933086445148
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),34739,-0.0048542300220748,0.0311816316646794,-0.0659702280848465,0.0562617680406969,0.876293576288865
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,34739,0.0125302478506796,0.0134093065091967,-0.0137519929073459,0.0388124886087051,0.350111592019352
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,34739,-0.00643837517467184,0.0214437564457069,-0.0484681378082574,0.0355913874589137,0.764000643544879
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,34739,-0.0273864297129512,0.0349189044320286,-0.0958274823997273,0.0410546229738249,0.432902206051155
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,34739,0.00608080923859735,0.0409329468668931,-0.074147766620513,0.0863093850977077,0.881909367617307
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,34739,0.0736404851780157,0.0264235819758553,0.0218502645053393,0.125430705850692,0.00533746348803265
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,34739,-0.0128775266802467,0.0381812413406322,-0.0877127597078857,0.0619577063473923,0.735922150791077
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,34739,-0.071899012992466,0.0374038288381926,-0.145210517515324,0.00141249153039154,0.0546222054390011
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,34739,-0.00471038022931769,0.0213884973733892,-0.0466318350811605,0.0372110746225251,0.825699667665822
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,34739,0.0193675162314533,0.0211243281774077,-0.0220361669962658,0.0607711994591725,0.359265302407117
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,34739,-0.0314110801604481,0.0314706695219942,-0.0930935924235567,0.0302714321026604,0.318267052162447
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29058.Recent feelings or nervousness or anxiety,34569,0.0629864381252399,0.118169415501532,-0.168625616257763,0.294598492508243,0.594040896424221
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29059.Recent inability to stop or control worrying,34572,-0.11834179132501,0.128392598715163,-0.36999128480673,0.133307702156709,0.356712845226958
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29060.Recent worrying too much about different things,34572,0.0482602530392655,0.112859768454014,-0.172944893130602,0.269465399209133,0.668948652619646
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29061.Recent trouble relaxing,34569,0.132667049676877,0.118973669052729,-0.100521341666472,0.365855441020226,0.264854239300889
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29062.Recent restlessness,34576,0.328085781051229,0.156061290448106,0.0222056517729409,0.633965910329517,0.0355698002474764
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29063.Recent easy annoyance or irritability,34566,0.157180939047141,0.114175105638832,-0.0666022680049691,0.380964146099251,0.168667338895369
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29064.Recent feelings of foreboding,34571,0.0997111176831499,0.140066302354714,-0.17481883493209,0.37424107029839,0.476563733107434
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,34739,-0.00813988123323021,0.0167162753913448,-0.0409037810002661,0.0246240185338057,0.626315773292673
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,34739,-0.0514976046485648,0.025178329362044,-0.100847130198171,-0.00214807909895853,0.0408663921752469
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',34739,0.00420447401757923,0.0355906440085006,-0.0655531882390819,0.0739621362742404,0.905965151203622
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,34739,0.00166150358532402,0.0346187755910666,-0.0661912965731665,0.0695143037438146,0.961722353803322
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29065#2.Symptoms of panic attack_Sweating,34739,-0.028528899057406,0.0218535640081432,-0.0713618845133666,0.0143040863985547,0.191786031308132
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,34739,0.004248586551468,0.027421376856252,-0.0494973120867859,0.0579944851897219,0.876876057872941
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,34739,-0.00375112147184677,0.0259276323824441,-0.0545692809414372,0.0470670379977437,0.88497097139625
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,34739,-0.0388292360207984,0.0271584083632283,-0.0920597164127259,0.0144012443711292,0.152844939485438
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,34739,-0.0641472298762118,0.0324151049617638,-0.127680835601269,-0.000613624151154776,0.0478684818779796
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29076.Felt loved as a child,34545,-0.116102975451298,0.0982555537853805,-0.308683860870643,0.0764779099680483,0.237394720319118
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29077.Physically abused by family as a child,34554,-0.0590099961704019,0.122613105967488,-0.299331683866678,0.181311691525874,0.630342388085665
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29078.Felt hated by family member as a child,34546,0.0588473669436674,0.138090276967158,-0.211809575911962,0.329504309799296,0.67001295088403
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29079.Sexually molested as a child,34530,0.244590927442993,0.191670208257377,-0.131082680741465,0.620264535627452,0.201969115118394
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29080.Someone to take to doctor when needed as a child,34542,-0.0313720466566552,0.147475051548799,-0.320423147692302,0.257679054378992,0.8315465647506
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,34550,-0.0550392173167814,0.218098543121286,-0.482512361834502,0.372433927200939,0.800771997688038
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29082.Belittlement by partner or ex-partner as an adult,34535,0.18007075341904,0.173168305185564,-0.159339124744666,0.519480631582746,0.298447423422029
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29083.Physical violence by partner or ex-partner as an adult,34560,0.0672406627443644,0.198756454862716,-0.322321988786559,0.456803314275288,0.735143908650798
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,34553,-0.191691122332718,0.636573874640229,-1.43937591662757,1.05599367196213,0.763326325689747
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,34546,0.133025521802492,0.343643333776076,-0.540515412398617,0.8065664560036,0.698693476170358
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29086.Experienced a violent or sexual assault,34564,-0.150913412250813,0.230380986590125,-0.602460145967459,0.300633321465832,0.512454271572108
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29087.Experienced a life-threatening injury or illness,34557,0.108102314486245,0.108363244998065,-0.104289645709963,0.320494274682452,0.318517732040394
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29088.Experienced a marital separation or divorce,34557,-0.0115101803361628,0.110461492605896,-0.22801470584372,0.204994345171394,0.917013475728763
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29089.Experienced the death of a spouse or partner,34568,-0.0323754942799538,0.167600714546285,-0.360872894790672,0.296121906230764,0.846832107035651
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,34559,0.16312158609676,0.130333376354916,-0.0923318315588758,0.418575003752396,0.21077505012174
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29091.Frequency of drinking alcohol,34553,0.104107533870991,0.0880421138433576,-0.06845500926199,0.276670077003972,0.237064821113235
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,34058,0.0378135459319382,0.0955572144184711,-0.149478594328265,0.225105686192142,0.692329815293083
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,34077,-0.0334551261486718,0.0942225809025434,-0.218131384717657,0.151221132420313,0.722554691285255
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29104.Ever used cannabis,34550,0.0914308316336035,0.114440775839124,-0.13287308901108,0.315734752278287,0.424359550590602
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29108.Ever thought that life not worth living,34530,0.0669207850527704,0.119594973757158,-0.167485363511259,0.301326933616799,0.575799468216834
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29109.Ever contemplated self-harm,34533,0.148815171330454,0.164751047983593,-0.174096882717389,0.471727225378297,0.366417706923203
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29111.Ever self-harmed,34545,0.336770556365476,0.26934083786282,-0.191137485845651,0.864678598576603,0.211220616094219
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,34547,0.0989028186527753,0.171025836541692,-0.236307820968942,0.434113458274492,0.563089110402973
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,35216,0.000254245860622886,0.0380032100459348,-0.0742320458294094,0.0747405375506552,0.994662301740676
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,35216,0.0101529424680905,0.0291342546037568,-0.0469501965552729,0.067256081491454,0.727484700647441
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,35216,0.0267078126184853,0.0352106404248529,-0.0423050426142264,0.095720667851197,0.448169523376763
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,35216,0.0117643145604406,0.0616304619287588,-0.109031390819927,0.132560019940808,0.848621754888833
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,34535,0.0968558304234718,0.102650577749158,-0.104339301964878,0.298050962811821,0.345438675308622
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X29153.Pain or discomfort today,34547,0.0270714617762183,0.0931651641990158,-0.155532260053853,0.209675183606289,0.771386567455996
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29154.Anxiety or depression today,34547,-0.0622063071530714,0.124731722140386,-0.306680482548228,0.182267868242086,0.617994527432598
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29166.Frequency of confiding in someone close,34400,-0.0116384276865387,0.0921590125886211,-0.192270092360236,0.168993236987159,0.899509620875502
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,34532,0.0099831822650457,0.00730945537739378,-0.00434335027464611,0.0243097148047375,0.172056614536803
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,34532,0.00751669503695979,0.00758241035421791,-0.00734482925730732,0.0223782193312269,0.321563346005992
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,34532,-0.0190924555224678,0.00805700977494328,-0.0348841946813567,-0.00330071636357901,0.0178357806142349
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,34532,-0.012865606660007,0.0110487371667074,-0.0345211315067535,0.00878991818673947,0.244292017525864
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,34532,-0.0214179800147217,0.0223449446273302,-0.065214071484289,0.0223781114548456,0.337841847463676
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,34532,-0.000387389794328019,0.00813165009324326,-0.0163254239770848,0.0155506443884288,0.962004954142334
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,34526,-0.00931252310349674,0.00853303862757062,-0.0260372788135352,0.00741223260654167,0.275163717181788
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,34526,0.0122842387914623,0.0134704389252654,-0.014117821502058,0.0386862990849825,0.36183713619285
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,34526,-0.00708994091862573,0.0152958388794635,-0.0370697851223743,0.0228899032851228,0.64300806488647
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,34526,0.0154441434078066,0.0187493883096755,-0.0213046576791574,0.0521929444947706,0.410134935390944
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,34526,-0.0550026732527786,0.0321538589167389,-0.118024236729587,0.0080188902240297,0.0872056967669851
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,34526,-0.000179257009724283,0.0122299714211996,-0.0241500009952756,0.023791486975827,0.988306166857956
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29171.Frequency of feeling 'in tune' with people,34380,-0.0148048440614444,0.112668271933433,-0.235634657050973,0.206024968928084,0.89546182599682
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29172.Freuency of feeling that lacks companionship,34491,0.149093472183586,0.104165236095616,-0.0550703905638208,0.353257334930994,0.152392442385102
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29173.Frequency of feeling left out,34466,0.236695971721155,0.107517030848122,0.0259625912588364,0.447429352183474,0.0277412756590377
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29174.Frequency of feeling isolated from others,34495,0.0962049937653764,0.112180276073638,-0.123668347338954,0.316078334869706,0.391152237949105
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29175.Tendency to bounce back quickly after hard times,34540,0.191760022813695,0.0909387542516314,0.0135200644804971,0.369999981146892,0.0350146644932493
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29176.Ability to make it through stressful events,34540,0.0772793560435715,0.0896381119267466,-0.0984113433328518,0.252970055419995,0.388652949393351
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29177.Quick recovery from stressful events,34540,0.124259718892512,0.0933847247916454,-0.058774341699113,0.307293779484137,0.183364700219961
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29178.Hard to snap back when something bad happens,34540,-0.0241489933787729,0.0893552818022043,-0.199285345711093,0.150987358953547,0.786971050966467
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29179.Comes through difficult times with little trouble,34540,0.00654965606789695,0.0915779529626669,-0.17294313173893,0.186042443874724,0.942986309037685
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29180.Tendency to take a long time to get over setbacks,34540,0.022756862172168,0.0913568437900311,-0.156302551656293,0.201816276000629,0.803293126763519
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29181.General happiness,34508,0.0859601063543697,0.091856753994553,-0.0940791314749542,0.265999344183694,0.349411329202169
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29182.Belief that own life is meaningful,34433,-0.107811084072779,0.0934146699153933,-0.29090383710695,0.0752816689613917,0.248501155521283
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,33827,-0.0745524864445258,0.100191560139406,-0.270927944317761,0.12182297142871,0.456849756755973
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X2946.Father's age,32743,0.0151963264419175,0.0062056491649094,0.00303325407869511,0.0273593988051399,0.0143748935953199
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X2966.Age high blood pressure diagnosed,34346,-0.0026184458663548,0.00441935064631386,-0.01128037313313,0.00604348140042036,0.553542072798658
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30000.White blood cell (leukocyte) count,47815,-0.00136263918058841,0.0019943276498553,-0.00527152137430479,0.00254624301312797,0.494452428154851
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,47816,0.000446458115004333,0.0021592933084133,-0.00378575676948574,0.0046786729994944,0.836198535678996
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30020.Haemoglobin concentration,47816,0.00204422787232176,0.00228732587661246,-0.00243893084583866,0.00652738659048219,0.371483150873516
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30030.Haematocrit percentage,47816,0.00273159220440511,0.00224380929901965,-0.0016662740216734,0.00712945843048362,0.22347061184995
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30040.Mean corpuscular volume,47816,0.00295113461304652,0.00197427547383233,-0.000918445315664847,0.00682071454175788,0.13498470217021
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30050.Mean corpuscular haemoglobin,47816,0.0019814459320065,0.00198038749535836,-0.00190011355889588,0.00586300542290889,0.317064528652991
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,47816,-0.00144887947886172,0.00193326623441243,-0.00523808129831008,0.00234032234058664,0.453597349259173
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,47816,0.000424754153726899,0.00201645196433147,-0.00352749169636278,0.00437700000381658,0.833167058941793
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30080.Platelet count,47816,0.000203535970391934,0.0019787295328691,-0.0036747739140315,0.00408184585481537,0.918073613477528
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30090.Platelet crit,47816,-0.000164268707142634,0.00201506434613521,-0.00411379482556765,0.00378525741128238,0.935029008007134
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,47816,-0.000565987001334467,0.00186554073732781,-0.00422244684649698,0.00309047284382805,0.76159570625483
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30110.Platelet distribution width,47816,1.49070374397958e-05,0.0019237038825251,-0.00375555257230939,0.00378536664718898,0.993817228656806
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30120.Lymphocyte count,47784,0.00095430607004499,0.00194105150894532,-0.00285015488748784,0.00475876702757782,0.622976751707452
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30130.Monocyte count,47784,-0.0034998464675574,0.00194924751189756,-0.00732037159087661,0.000320678655761822,0.0725920459488119
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30140.Neutrophill count,47784,-0.00185680444046803,0.00197591594380001,-0.00572959969031605,0.00201599080937999,0.347373889465057
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30150.Eosinophill count,47784,0.00212868656221175,0.00187395573479387,-0.00154426667798424,0.00580163980240774,0.255999153121316
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30160.Basophill count,47784,0.124962775940749,0.0576833139298227,0.0119034806382965,0.238022071243201,0.0302960251538881
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30170.Nucleated red blood cell count,47784,0.242072699168287,0.284021685077027,-0.314609803582686,0.798755201919261,0.394056259644757
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30180.Lymphocyte percentage,47785,0.00205651174058786,0.00192379698529989,-0.00171413035059991,0.00582715383177564,0.285089498627546
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30190.Monocyte percentage,47785,-0.00279544366970087,0.00192592525133187,-0.00657025716231133,0.000979369822909588,0.146662355136607
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30200.Neutrophill percentage,47785,-0.00168991768368973,0.00189935840103318,-0.00541266014971477,0.00203282478233531,0.373621603932935
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30210.Eosinophill percentage,47785,0.00196531582785978,0.00185832108541958,-0.0016769934995626,0.00560762515528216,0.290262093299968
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30220.Basophill percentage,47785,0.00336470267294715,0.00194932690725219,-0.000455978065267135,0.00718538341116144,0.0843483386694667
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30230.Nucleated red blood cell percentage,47784,0.247834615201371,0.283889011547737,-0.308587847432193,0.804257077834935,0.382674949480673
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30240.Reticulocyte percentage,47479,-0.000240022175706985,0.00204762510323467,-0.00425336737804693,0.00377332302663297,0.906687135248306
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30250.Reticulocyte count,47479,-2.86521447999757e-05,0.00207088828150637,-0.00408759317655246,0.00403028888695251,0.988961223998565
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30260.Mean reticulocyte volume,47479,0.000698404872130027,0.00194209776728304,-0.00310810675174474,0.00450491649600479,0.71914009456095
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30270.Mean sphered cell volume,47479,0.0024220556050874,0.00195045707568037,-0.00140084026324612,0.00624495147342092,0.214329950606207
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30280.Immature reticulocyte fraction,47479,-0.000248945565071929,0.00201770170250745,-0.00420364090198653,0.00370574977184267,0.90180690710782
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30290.High light scatter reticulocyte percentage,47479,1.29275015151751e-05,0.00207439110197659,-0.00405287905835894,0.00407873406138929,0.995027721386212
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30300.High light scatter reticulocyte count,47479,0.000231590579332982,0.00208539285096583,-0.00385577940856005,0.00431896056722601,0.911574948968193
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30500.Microalbumin in urine,35655,0.000102967515198821,0.00294795429481216,-0.00567502290263301,0.00588095793303065,0.972137771679352
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,47853,-0.00193946276215593,0.00208152207782083,-0.00601924603468475,0.0021403205103729,0.351476289504146
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30520.Potassium in urine,47818,2.96265612823715e-05,0.00194111337080393,-0.00377495564549334,0.00383420876805808,0.987822787209871
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30530.Sodium in urine,47823,-0.00180115744982233,0.0020129401770851,-0.00574652019690912,0.00214420529726447,0.370910903201806
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30600.Albumin,46029,0.0050877955581992,0.00206026150690419,0.00104968300466698,0.00912590811173141,0.0135400833217695
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30610.Alkaline phosphatase,47451,-0.00319802367338052,0.00204462957352624,-0.00720549763749194,0.000809450290730902,0.117808740669924
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30620.Alanine aminotransferase,47436,-0.00164945793226447,0.00219745015408716,-0.00595646023427531,0.00265754436974637,0.452888594103524
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30630.Apolipoprotein A,45976,0.00245200841254419,0.00222936130521526,-0.00191753974567772,0.0068215565707661,0.271403849902153
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30640.Apolipoprotein B,47318,0.00194297397820949,0.00191147676373784,-0.00180352047871668,0.00568946843513565,0.309414981699638
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30650.Aspartate aminotransferase,47382,-0.000598824305479415,0.00202186066056888,-0.00456167120019442,0.00336402258923559,0.767099818584408
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30660.Direct bilirubin,46143,0.00393384841907665,0.00207224200584629,-0.000127745912382074,0.00799544275053538,0.0576658911250973
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30670.Urea,47440,-0.00285260975792525,0.00201545651448127,-0.00680290452630855,0.00109768501045804,0.156977577529163
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30680.Calcium,46022,0.00110146927365063,0.00204318201507541,-0.00290316747589716,0.00510610602319843,0.589828172090195
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30690.Cholesterol,47454,0.00223973365720843,0.0019260912874259,-0.00153540526614632,0.00601487258056319,0.244909634391304
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30700.Creatinine,47446,-0.000146610694206508,0.00254380162073302,-0.00513246187084322,0.00483924048243021,0.954040391956814
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30710.C-reactive protein,47381,-0.00571107021546748,0.00212329848711133,-0.00987273525020569,-0.00154940518072927,0.00715760064687839
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30720.Cystatin C,47459,-0.00253050052510864,0.00233074853619514,-0.00709876765605111,0.00203776660583384,0.277624319537443
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30730.Gamma glutamyltransferase,47442,-0.00413613674436017,0.00231901571258966,-0.00868140754103591,0.000409134052315564,0.0745089608493425
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30740.Glucose,45999,0.0027782801828336,0.00195104880602466,-0.00104577547697472,0.00660233584264193,0.154466381084544
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),47365,-0.00221501139687267,0.00196138834941428,-0.00605933256172466,0.00162930976797933,0.258782397122007
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30760.HDL cholesterol,46009,0.00395233678931122,0.00230117720132526,-0.000557970525286295,0.00846264410390874,0.085900486411346
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30770.IGF-1,47367,0.000862473047950936,0.00205351539523751,-0.00316241712671458,0.00488736322261645,0.674491477812726
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30780.LDL direct,47410,0.0022047821869825,0.00192199471233435,-0.00156232744919283,0.00597189182315782,0.251341542902835
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30790.Lipoprotein A,43655,-0.000501034441221904,0.00212293412350766,-0.00466198532329691,0.0036599164408531,0.813427843634016
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30810.Phosphate,45982,0.00251606409276054,0.00198543023095189,-0.00137537915990516,0.00640750734542624,0.205077915426916
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30830.SHBG,45904,0.00439845646526383,0.0026449492773131,-0.000785644118269851,0.00958255704879751,0.0963376736948249
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30840.Total bilirubin,47373,0.0034899794257992,0.00209319101212868,-0.000612674957973013,0.00759263380957142,0.0954712517441948
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30850.Testosterone,47270,0.00413868196348611,0.0032838349591496,-0.00229763455644711,0.0105749984834193,0.207569799741851
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30860.Total protein,45999,0.000573155849437643,0.00202552657849292,-0.00339687624440849,0.00454318794328377,0.777206003367129
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30870.Triglycerides,47432,-0.00258597803720531,0.00200673041937653,-0.00651916965918331,0.00134721358477268,0.197534776783565
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30880.Urate,47429,-0.000389298732473882,0.00241850016646408,-0.00512955905874349,0.00435096159379572,0.872121113491449
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30890.Vitamin D,46885,-0.00159419037544931,0.00217134672980832,-0.00585002996587362,0.002661649214975,0.462839746050887
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X3137.Number of measurements made,46346,0.0176997212437096,0.0681566697163447,-0.115887351400326,0.151286793887745,0.795104610255549
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X3143.Ankle spacing width,39693,0.00251463740411241,0.00350742752048292,-0.0043599205360341,0.00938919534425893,0.473422287680649
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",39693,-0.000255875420670542,0.00253601852470049,-0.00522647172908351,0.00471472088774242,0.919634436324889
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X3146.Speed of sound through heel,39693,-0.000447869892403359,0.00246387936780528,-0.00527707345330171,0.00438133366849499,0.85576319287474
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",39693,-0.000363430847743613,0.00248350869557811,-0.00523110789107672,0.00450424619558949,0.883657497629347
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X3148.Heel bone mineral density (BMD),39675,-5.6285487542371e-05,0.00250212547899604,-0.0049604514263746,0.00484788045128986,0.98205344991339
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X3526.Mother's age at death,40381,-0.000897482607867163,0.00245851926569525,-0.00571618036862985,0.00392121515289552,0.715080590682986
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",32245,-0.00186459768004935,0.00475316209606164,-0.0111807953883302,0.00745160002823146,0.694870039386857
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4100.Ankle spacing width (left),35043,0.000292313411964341,0.00458668583396902,-0.00869759082261494,0.00928221764654362,0.949186512591119
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4101.Heel broadband ultrasound attenuation (left),35041,0.00354438955448007,0.00331761457666318,-0.00295813501577975,0.0100469141247399,0.285400522469804
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4103.Speed of sound through heel (left),35043,0.00466194697039377,0.00318517501577858,-0.00158099606053225,0.0109048900013198,0.14334134261467
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",35043,0.00431774341527064,0.00322714023760909,-0.00200745145044319,0.0106429382809845,0.180960851161614
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4105.Heel bone mineral density (BMD) (left),35036,0.00398351875226468,0.00323676615931505,-0.00236054291999281,0.0103275804245222,0.218476521960132
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",35043,0.00431921800040529,0.00322737851658133,-0.00200644389209411,0.0106448798929047,0.180844137315489
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4119.Ankle spacing width (right),35033,0.00257198955765508,0.00452073661501969,-0.00628865420778351,0.0114326333230937,0.569422474730549
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4120.Heel broadband ultrasound attenuation (right),35032,-0.000838913983252799,0.00334349319203367,-0.0073921606396388,0.0057143326731332,0.801892145364201
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4122.Speed of sound through heel (right),35033,-6.45956066081632e-05,0.00317169822377592,-0.00628112412520897,0.00615193291199264,0.98375183656035
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",35033,-0.000507384882586993,0.00323059666757357,-0.00683935435103119,0.00582458458585721,0.875205571511217
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4124.Heel bone mineral density (BMD) (right),35025,-0.000454784191858504,0.00323827897953938,-0.0068018109917557,0.00589224260803869,0.888316686735968
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",35033,-0.000506053459735355,0.00323060871697139,-0.00683804654499929,0.00582593962552858,0.87553082999697
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4194.Pulse rate,35361,-0.00472677292213761,0.00298250230770048,-0.0105724774452306,0.00111893160095533,0.11305068188465
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4195.Pulse wave reflection index,35361,0.000362027896011136,0.00312476762359353,-0.00576251664623219,0.00648657243825446,0.907768886456382
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4196.Pulse wave peak to peak time,35354,0.000476729912032855,0.00345400178359766,-0.00629311358381855,0.00724657340788426,0.890226761072622
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4198.Position of the pulse wave peak,35361,-0.00662151820568883,0.00372305892568511,-0.0139187137000317,0.000675677288653993,0.0753641446730386
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4199.Position of pulse wave notch,35361,-0.00545127820018448,0.00301515766626871,-0.0113609872260712,0.000458430825702198,0.0706574682157108
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4200.Position of the shoulder on the pulse waveform,35361,-0.00647544860639689,0.00379286471878063,-0.0139094634552069,0.000958566242413147,0.0878175746910496
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4269.Number of triplets attempted (left),35167,-0.032731949291977,0.286241253994388,-0.593764807120977,0.528300908537023,0.908963126135934
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4270.Volume level set by participant (left),35095,-0.106169154416214,0.0910575693344757,-0.284641990311787,0.0723036814793579,0.243674912490542
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4276.Number of triplets attempted (right),35170,0.147599650091406,0.292175532748801,-0.425064394096245,0.720263694279056,0.613453206062681
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4277.Volume level set by participant (right),35099,-0.127362331798644,0.0902042117262368,-0.304162586782068,0.04943792318478,0.158017495608888
PRAME,Melanoma antigen preferentially expressed in tumors,Cognitive function,X4288.Time to answer,35331,-0.0051532415926937,0.00358861067505701,-0.0121869185158054,0.00188043533041805,0.151049076673589
PRAME,Melanoma antigen preferentially expressed in tumors,Cognitive function,X4290.Duration screen displayed,35331,-0.00571450360490441,0.0032943605075701,-0.0121714501997418,0.000742442989932999,0.0828517612582661
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X46.Hand grip strength (left),48316,0.00717762366857058,0.00254810685834139,0.00218333422622145,0.0121719131109197,0.00485460269814707
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X47.Hand grip strength (right),48317,0.00353492442597,0.00252042530787521,-0.00140510917746541,0.00847495802940541,0.160778427953468
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X48.Waist circumference,48368,-0.00367219747921153,0.00477543659604568,-0.0130320532074611,0.005687658249038,0.441916577813317
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X4803.Tinnitus,35198,0.0236934329913284,0.104217898310416,-0.180573647697086,0.227960513679743,0.820162419968199
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X4825.Noisy workplace,35272,0.0539537446080742,0.0970827993120812,-0.136328542043605,0.244236031259753,0.578400559320784
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X4836.Loud music exposure frequency,35228,-0.145845958358741,0.134217782043007,-0.408912811163035,0.117220894445552,0.277236957993005
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X49.Hip circumference,48362,-0.000346315355835719,0.00350460912484312,-0.00721534924052824,0.0065227185288568,0.921284483059955
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X50.Standing height,48329,0.00259820150679673,0.00264863655793884,-0.00259312614676338,0.00778952916035685,0.326625429232043
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X5057.Number of older siblings,34503,0.0226865897237091,0.095131544497868,-0.163771237492112,0.20914441693953,0.811520210812199
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X51.Seated height,48246,0.000941747044856087,0.00230885231216581,-0.00358360348698891,0.00546709757670108,0.683362289884275
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X5181.Ever had eye surgery,33154,-0.50587232791603,0.225091946061792,-0.947052542197142,-0.0646921136349174,0.0246619798585925
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X5186.Duration visual-acuity screen displayed (right),33144,-0.00103469169534481,0.00387415324733935,-0.00862803206012992,0.00655864866944031,0.78942309506841
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X5188.Duration visual-acuity screen displayed (left),33141,0.000866889035046458,0.00398645140532751,-0.00694655571939547,0.00868033378948838,0.827860562680354
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X5190.Duration at which refractometer first shown (right),33096,0.0013729907613771,0.00400007755511096,-0.00646716124664039,0.00921314276939459,0.731433184211897
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X5193.Duration at which refractometer first shown (left),33093,0.00113512637870693,0.00404359026054876,-0.00679031053196864,0.0090605632893825,0.778936248790165
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,"X5199.logMAR, initial (right)",33123,-0.0675961353265281,0.10976838638223,-0.282742172635699,0.147549901982643,0.538052932302526
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X5200.Final number of letters displayed (right),33123,1.67008813514757,0.68267080516101,0.332053357031995,3.00812291326315,0.0144667870669045
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,"X5201.logMAR, final (right)",33071,-0.000690593507320766,0.00386479432746971,-0.0082655903891614,0.00688440337451987,0.858190556916769
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X5202.Number of rounds to result (right),33123,-0.0582363223183929,0.102711073583845,-0.259550026542729,0.143077381905943,0.57074805136257
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,"X5206.logMAR, initial (left)",33119,-0.00774530883369285,0.111490735797844,-0.226267150997468,0.210776533330082,0.944618247379093
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X5207.Final number of letters displayed (left),33119,0.068650965520922,0.709750467080721,-1.32245994995729,1.45976188099914,0.922948683507261
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,"X5208.logMAR, final (left)",33080,-0.00391631713340411,0.0039099981196333,-0.0115799134478854,0.00374727918107716,0.316583129446951
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X5209.Number of rounds to result (left),33115,0.14771349579827,0.104095177025324,-0.0563130511713658,0.351740042767906,0.155961380102806
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",32951,-0.00268715734586668,0.0038703972990969,-0.0102731360520966,0.00489882136036326,0.487540797392359
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",32951,-0.0017521521830837,0.00380718771473012,-0.00921424010395473,0.00570993573778734,0.645379758603914
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X5256.Corneal hysteresis (right),32951,0.00136383511470787,0.00394997507830666,-0.00637811603877318,0.00910578626818892,0.72990290850557
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X5257.Corneal resistance factor (right),32951,-0.000113113252520961,0.00389864353709605,-0.00775445458522922,0.0075282280801873,0.976855162865274
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",32929,-0.00128392992049522,0.00388516093537012,-0.00889884535382065,0.0063309855128302,0.741060696437218
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",32929,-0.00225102421580463,0.00386351698069264,-0.0098235174979622,0.00532146906635294,0.560168686863937
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X5264.Corneal hysteresis (left),32929,-0.00205646463051238,0.00388736482389571,-0.00967569968534797,0.00556277042432321,0.596823893041804
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X5265.Corneal resistance factor (left),32929,-0.00356340838647769,0.00388248863319071,-0.0111730861075315,0.00404626933457609,0.35876657799253
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,33691,-0.105311122118536,0.551094906272384,-1.18545713841241,0.974834894175336,0.84845929683218
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",48324,-0.00396634204791114,0.0103513222329489,-0.024254933624491,0.0163222495286687,0.70159599399185
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",48324,-0.0237693314710931,0.0117941807193842,-0.0468859256810861,-0.000652737261100041,0.0438821549416303
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",48324,0.0287634079050385,0.0296151022476194,-0.0292821925002955,0.0868090083103726,0.331440084114153
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",48324,-0.0030850684093728,0.004711903869022,-0.0123203999926559,0.00615026317391033,0.512643284119381
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",48324,0.00364458267827622,0.00437040346669849,-0.00492140811645282,0.0122105734730053,0.404334125282904
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",37255,-0.0103256868454429,0.00557063503701206,-0.0212441315179865,0.000592757827100741,0.0638314979643547
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",37255,-0.00925015301725178,0.0171150557282197,-0.0427956622445624,0.0242953562100589,0.588887704071466
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",37255,-0.0074525041685083,0.0107145253115858,-0.0284529737792166,0.0135479654422,0.486728422137622
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",37255,-0.00490717630969721,0.00648257289487683,-0.0176130191836558,0.00779866656426137,0.44908260956432
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,48381,-0.00212401990343318,0.00987892040808014,-0.0214867039032703,0.0172386640964039,0.829765429918865
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,48381,-0.00212401990343318,0.00987892040808014,-0.0214867039032703,0.0172386640964039,0.829765429918865
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),48381,0.0133712298970951,0.00721408959682366,-0.000768385712679228,0.0275108455068695,0.0638272956099818
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',48381,0.00370899288546386,0.012708182732601,-0.0211990452704342,0.0286170310413619,0.7703977710325
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),48381,-0.00688282034932346,0.0306406370602369,-0.0669384689873878,0.0531728282887409,0.822269088131227
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),48381,0.0220061143641108,0.0212121598819405,-0.0195697190044926,0.0635819477327143,0.299548550134058
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,48381,0.0331043499427027,0.0325092884605618,-0.0306138554399986,0.0968225553254039,0.308545794640912
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,48323,-0.0119061229214498,0.00643731162921089,-0.0245232537147032,0.000711007871803497,0.0643935379389959
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,48323,-0.00398941899132776,0.0112281640276873,-0.0259966204855948,0.0180177825029393,0.722365164960384
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,48323,0.00619845234740848,0.00584582114048219,-0.00525935708793661,0.0176562617827536,0.289011150481395
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,48323,0.0167649899129006,0.0086104045727901,-0.000111403049767967,0.0336413828755692,0.0515414993729588
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,48323,0.00310259875210996,0.00872906353084492,-0.0140063657683461,0.020211563272566,0.722268901319884
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,48323,-0.00631355353367693,0.0049650525545225,-0.016045056540541,0.00341794947318716,0.203530793468519
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,35684,0.00947959576181969,0.00903395689104931,-0.00822695974463695,0.0271861512682763,0.294062376831635
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,35684,-0.00447621964474808,0.00865661685255972,-0.0214431886757651,0.012490749386269,0.605111926007733
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,35684,0.00234699055920794,0.0125329732193775,-0.022217636950772,0.0269116180691879,0.851458018164553
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,35684,-0.00446199933290422,0.00930490712089509,-0.0226996172898586,0.0137756186240502,0.631575118478777
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,48281,-0.0131183896822782,0.0172952764058774,-0.0470171314377978,0.0207803520732414,0.448163476408354
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6151#2.Fractured bone site(s)_Leg,48281,0.0538821285823688,0.0215782048999857,0.0115888469783969,0.0961754101863407,0.0125307902456897
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6151#3.Fractured bone site(s)_Hip,48281,-0.0397349101264469,0.040489437459573,-0.11909420754721,0.0396243872943161,0.326424923868195
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6151#4.Fractured bone site(s)_Spine,48281,0.00241847257736855,0.0395212988566545,-0.0750432731816743,0.0798802183364114,0.951205204214827
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,48281,0.00168366849281041,0.0163217917033725,-0.0303070432457997,0.0336743802314205,0.917841293482216
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6151#6.Fractured bone site(s)_Arm,48281,-0.00992575273853872,0.0191798138261766,-0.0475181878378448,0.0276666823607674,0.604805741301257
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,48281,0.00488110621490151,0.00810748525731528,-0.0110095648894364,0.0207717773192395,0.547148224812585
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",34538,-0.0104870647716938,0.0144751487038972,-0.0388583562313324,0.0178842266879448,0.468795022456823
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",34538,-0.0130506400480987,0.014013330007034,-0.0405167668618853,0.0144154867656879,0.351735310723642
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",34538,-0.0460555253757648,0.0203576049167957,-0.0859564310126844,-0.00615461973884512,0.0237132952966792
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",34538,-0.00180578046208145,0.00727530104123507,-0.0160653705029022,0.0124538095787393,0.803982852908097
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",37156,-0.00724516895584667,0.00586684727328105,-0.0187441896114775,0.00425385169978418,0.216888993613933
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",37156,0.00664932895609417,0.00647256879836449,-0.00603690588870023,0.0193355638008886,0.304303970700209
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",37156,-0.00294785384064172,0.00573679101898206,-0.0141919642378465,0.00829625655656311,0.60736967689195
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",37157,-0.00111458308926688,0.0133000465022632,-0.0271826742337028,0.024953508055169,0.933215065383124
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",37157,0.00770983874363971,0.00795789376277665,-0.00788763303140251,0.0233073105186819,0.332657866353919
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",37157,-0.00705987751767716,0.0145560927121026,-0.0355898192333983,0.021470064198044,0.627680352400786
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,48323,0.00464998342995359,0.0127015223484708,-0.0202450003730492,0.0295449672329563,0.714296963208667
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,48323,0.00468666061570719,0.0102189069745911,-0.0153423970544913,0.0247157182859057,0.646507521796429
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,48323,-0.0322815340322379,0.0211090501205626,-0.0736552722685406,0.00909220420406467,0.126212422456381
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,48323,0.0162177150204105,0.0114304620987513,-0.00618599069314205,0.0386214207339631,0.155968659726509
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,48323,0.00915216501417183,0.0116984621995993,-0.0137768208970429,0.0320811509253865,0.434024674742414
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),48323,-0.0187644499020832,0.0141274682611237,-0.0464542876938856,0.0089253878897193,0.184119312046839
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,48323,-0.00392098890828673,0.00412632006403847,-0.0120085762338021,0.00416659841722868,0.34200263516153
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,33301,-0.0131785963243154,0.0099660827483553,-0.0327121185110918,0.00635492586246101,0.186117737702493
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,33301,-0.0183876627911053,0.0120580562259451,-0.0420214529939577,0.00524612741174707,0.127344424301543
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,33301,0.000591189757133864,0.00897873376867093,-0.0170071284294612,0.0181895079437289,0.947505356152835
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,33301,0.00707787576611959,0.00803080229260471,-0.00866249672738565,0.0228182482596248,0.378178309074062
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,48409,-0.000624033555990508,0.00500190209402419,-0.0104277616602779,0.0091796945482969,0.90071541465553
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,48409,0.0173842242162763,0.0162906946274854,-0.0145455372535951,0.0493139856861476,0.285927935915697
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,48409,0.0030345415995395,0.0044157376656541,-0.00562030422514254,0.0116893874242215,0.491958089501892
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,48409,0.00782225864549431,0.00413534487521358,-0.000283017309924305,0.0159275346009129,0.0585640196102468
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,48409,0.000619400411507866,0.00704452306107123,-0.0131878647881917,0.0144266656112075,0.929935965567469
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,48409,-0.00246812253709059,0.00627971338144591,-0.0147763607647246,0.0098401156905434,0.694300755108005
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,48409,-0.000946082237614493,0.0044594486767624,-0.0096866016440688,0.00779443716883982,0.8319904112685
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,48409,-0.0215162697162146,0.0144654024078974,-0.0498684584356936,0.00683591900326432,0.13691726440357
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,42369,-0.00952273195305719,0.00455553685300977,-0.0184515841849563,-0.000593879721158031,0.0366033746327173
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,42369,-0.00217151344910589,0.00448647938642604,-0.0109650130465009,0.00662198614828915,0.628384483018538
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,42369,0.00394727213432338,0.00579343468798846,-0.007407859854134,0.0153024041227808,0.495670747979812
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,42370,-0.00447396015939759,0.00900007417938956,-0.0221141055510011,0.0131661852322059,0.619124646855565
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,42370,0.00055335198928582,0.00514345602937828,-0.0095278218282956,0.0106345258068672,0.914327501172733
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,48227,-0.00351753035165587,0.00475397183613932,-0.0128353151504889,0.00580025444717721,0.459361024555757
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,48227,0.00483192867223067,0.00373182624082409,-0.00248245075978455,0.0121463081042459,0.19540815684232
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,48227,0.00358923545155318,0.00422083669721627,-0.00468360447499071,0.0118620753780971,0.395134714545339
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,48227,0.00867153146460597,0.00645108695824693,-0.00397259897355801,0.0213156619027699,0.178900241482524
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),48245,-0.00235874735384753,0.00401307598616066,-0.0102243762867224,0.00550688157902736,0.556696503333692
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,48245,0.00486325280162323,0.00561609864570348,-0.0061443005439556,0.0158708061472021,0.38652892074897
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),48323,0.000396522263743777,0.00409713872301767,-0.00763386963337085,0.00842691416085841,0.922901862039808
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,48323,0.00637679101325478,0.00514906661501934,-0.00371537955218313,0.0164689615786927,0.215569067171593
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,48323,-0.0108022139118332,0.0108543405356765,-0.0320767213617591,0.0104722935380928,0.319652366380865
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,48323,0.00675237809329968,0.0101839878927578,-0.0132082381765057,0.026712994363105,0.507313517445871
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,48323,-0.00494872249254833,0.0122324428112839,-0.0289243104026648,0.0190268654175682,0.685807430765136
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,48323,-0.00275415760290982,0.0124167137515487,-0.0270909165559453,0.0215826013501257,0.824463694355668
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",39693,-0.000363211018870489,0.00248351572077287,-0.00523090183158532,0.00450447979384434,0.883727695937384
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X864.Number of days or week walked 10+ minutes,48021,-0.0574156733317793,0.0509551191663857,-0.157287706897895,0.0424563602343366,0.259845582596125
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X874.Duration of walks,45787,-0.00322748714808081,0.00192935152664543,-0.00700901614030586,0.00055404184414424,0.09437794306399
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,47497,-0.0370963981116314,0.0488256252602436,-0.132794623621709,0.058601827398446,0.447399688196227
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X894.Duration of moderate activity,43468,0.0417229514759089,0.0590245600487106,-0.0739651862195637,0.157411089171382,0.479655602186653
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X90087.No-wear time bias adjusted average acceleration,32471,0.00672330308232687,0.00444897730041706,-0.00199669242649056,0.0154432985911443,0.130818635166546
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,47430,0.0189886686199413,0.0502970623649472,-0.0795935736153552,0.117570910855238,0.705783754772059
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X914.Duration of vigorous activity,39862,0.000825030447692571,0.00230841410313541,-0.00369946119445283,0.00534952208983798,0.720798020893746
